Supplementary Information Tables 2020-21 Departmental Plan: Health Canada

Table of Contents

Details on Transfer Payment Programs

Transfer Payment Programs of $5 Million or More

3-year plan for Canada Brain Research Fund Program

Start date
April 1, 2011
End date
March 31, 2022
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2019-20
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems.
Link to the department’s Program Inventory
Program 14: Brain Research
Purpose and objectives of transfer payment program
In Budgets 2011, 2016, and 2019, the Government of Canada committed up to $160 million, in matched funding with non-federal government donors, for the Canada Brain Research Fund Program "to support the very best Canadian neuroscience” and “to help the medical community better understand the brain and brain health.” The Government of Canada's objectives in funding the Canada Brain Research Fund are: 1) to serve as a focal point for private investment in brain research by attracting private and charitable donations to match federal funding; and, 2) to support research that advances knowledge of the brain through grants to researchers.
Expected results
The Canada Brain Research Fund's support for brain research is expected to lead to discoveries that will inform the development of prevention, diagnostic, therapeutic, clinical, technological and health system solutions for brain diseases/disorders. Ultimately, these advances are expected to improve the health and quality of life of Canadians who are at risk of or affected by brain diseases/disorders. To contribute to this outcome, the Recipient, in partnership with various donors and private organizations, funds competitively-awarded research grants across Canada.
Fiscal year of last completed evaluation
2016-17
Decision following the results of last evaluation
Not applicable
Fiscal year of next planned evaluation
TBD
General targeted recipient groups
The sole target recipient is the national non-profit organization Brain Canada, which acts as a third-party organization that raises and disburses funds for brain research. Through the Canada Brain Research Fund, delivered by Brain Canada, the Program allocates grants to researchers across Canada targeting research institutes, hospitals and health charities.
Initiatives to engage applicants and recipients
The Recipient is continuously engaged through regular monitoring activities such as reporting, performance measurement, meetings and ongoing communication in support of program design and delivery.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spendingFootnote 1
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 13,174,646 24,676,683 20,000,000 0
Total other types of transfer payments 0 0 0 0
Total program 13,174,646 24,676,683 20,000,000 0
Table 1 Footnote 1

The planned spending includes $4.7 million in funding which has been carried over and is included in the 2020-21 planned spending.

Table 1 Return to footnote 1 referrer

3-year plan for Canadian Blood Services: Blood Research and Development Program

Start date
April 1, 2000
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2013-14
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 12: Blood System, Organs, Tissue and Transplantation
Purpose and objectives of transfer payment program
The Canadian Blood Services: Blood Research and Development Program (CBS - Blood R&D Program) helps maintain and increase the safety, supply and efficiency of the Canadian blood system by advancing innovation and maintaining Canadian capacity in transfusion science and medicine. The Program pursues these goals by fostering relevant discovery and development research, facilitating dissemination and application of knowledge, educating the next generation of scientific and health care experts, and engaging with an interdisciplinary network of partners in Canada and beyond.
Expected results

The CBS – Blood R&D Program is expected to generate numerous knowledge products (e.g., journal articles, reviews, etc.) and learning events (e.g., presentations at national and international conferences). It also plays a significant role in the development of highly qualified people through formal training in the important areas of basic and applied research. In particular, the Program is expected to build and maintain research capacity in transfusion science and medicine (for example, through graduate fellowship programs, postdoctoral fellowship programs, and provision of training positions in research laboratories). The Program is expected to develop research networks, collaborative arrangements, establish partnerships and award funding grants in support of R&D and training.

In addition, it is expected that various stakeholders, including Health Canada and blood operators in Canada, will use the knowledge generated by Blood R&D projects to inform changes to practices and standards. This will contribute to greater safety, supply and quality of the Canadian blood system.

Fiscal year of last completed evaluation
2017-18
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2022-23
General targeted recipient groups
CBS is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada officials undertake numerous exchanges (meetings, phone calls, e-mails and knowledge transfer activities) with CBS Program staff and senior management to discuss Program progress. In addition, Health Canada continues to monitor the Recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance and financial reporting.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 5,000,000 5,000,000 5,000,000 5,000,000
Total other types of transfer payments 0 0 0 0
Total program 5,000,000 5,000,000 5,000,000 5,000,000

3-year plan for the Contribution to the Canadian Foundation for Healthcare Improvement

Start date
December 10, 2015
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems
Link to the department’s Program Inventory
Program 1: Health Care Systems Analysis and Policy
Purpose and objectives of transfer payment program
The contribution to the Canadian Foundation for Healthcare Improvement (CFHI) supports the federal government's interest in achieving an accessible, high quality, sustainable and accountable health system, adaptable to the needs of Canadians. It is designed to support CFHI's work to: find and promote health care innovators and innovations; drive rapid adoption of proven innovations; enable improvement-oriented systems; and, shape the future of healthcare.

CFHI previously operated as the Canadian Health Services Research Foundation (CHSRF), an arm's-length, non-profit, charitable organization with a mandate to fund health services research and promote the use of research evidence to strengthen the delivery of health services. CHSRF received $151.5 million in federal funding under three separate grants (1996-97 to 2003-04).

Expected results

CFHI’s work is guided by a strategy for the period of 2019 to 2021, which outlines its vision of being an indispensable partner in shaping better healthcare for everyone in Canada.

Over the coming years, CFHI's activities are expected to result in: health care leaders that are knowledgeable and skilled in carrying out health care improvements; patients, residents, family members, communities and others with lived experience that are engaged in health care improvement and co-design; and improvements to the cultures of participating organizations. Over time, this work is expected to lead to improvements to: patient, resident and family experience of care; the health of patients and residents reached; efficiency of care; and work life of healthcare providers. Ultimately, CFHI will work to sustain, spread and/or scale proven innovative policies and practices within and across organizations, regions and provinces/territories.

Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
CFHI is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada works with CFHI to establish activities to be carried out under the contribution agreement and maintains regular contact with CFHI to monitor progress and compliance under the contribution agreement.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 17,000,000 17,000,000 17,000,000 17,000,000
Total other types of transfer payments 0 0 0 0
Total program 17,000,000 17,000,000 17,000,000 17,000,000

Note: CFHI is also reported under the “Up-Front Multi-Year Funding” section of the Supplementary Information Tables.

3-year plan for Canadian Thalidomide Survivors Support Program

Start date
March 22, 2019
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2018-19
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 15: Thalidomide
Purpose and objectives of transfer payment program

The Program objectives are to ensure that, for the remainder of their lives, eligible thalidomide survivors:

  • receive ongoing tax-free payments based on their level of disability; and
  • have transparent and timely access to the Extraordinary Medical Assistance Fund.
Expected results
Expected results are that thalidomide survivors will access care, treatment and/or support which in turn will contribute to their aging with dignity.
Fiscal year of last completed evaluation
Not applicable
Decision following the results of last evaluation
Not Applicable
Fiscal year of next planned evaluation
2024-25
General targeted recipient groups
Canadian not-for-profit and for-profit organizations.
Initiatives to engage applicants and recipients
Applicants and recipients are engaged through regular meetings and ongoing communication and consultations to support simple, pro-active, accessible program delivery to meet the needs of thalidomide survivors. Key stakeholders were engaged in program design.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 13,418,765 14,546,067 12,503,960 12,655,092
Total other types of transfer payments 0 0 0 0
Total program 13,418,765 14,546,067 12,503,960 12,655,092

3-year plan for Contribution to Canada Health Infoway

Start date
April 1, 2016
End date
March 31, 2022
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems
Result 2: Canadians have access to appropriate and effective health services.
Link to the department’s Program Inventory
Program 6: Digital Health
Purpose and objectives of transfer payment program

Canada Health Infoway (Infoway) is an independent, not-for-profit corporation that is federally funded to work with jurisdictions and other stakeholders to support the development and adoption of digital health technologies across Canada. Between 2001 and 2010, the Government of Canada has invested $2.1 billion in Infoway, through grants or up-front multi-year funding, to focus on electronic health records, and other priorities in digital health. Budget 2016 allocated $50 million over two years to Infoway to support short-term digital health activities in e-prescribing and telehomecare, with the funds flowing as a Contribution Agreement. Budget 2017 allocated $300 million over five years to Infoway to expand e-prescribing and virtual care initiatives, support the continued adoption and use of electronic medical records, help patients to access their own health records electronically, and better link electronic health record systems to improve access by all providers and institutions. These funds also flow through a Contribution agreement.

Infoway is currently undertaking its Driving Access to Care Strategy which is comprised of two programs: PrescribeIT and ACCESS Health. To date, 10 jurisdictions have formally agreed to participate in the PrescribeIT program (all except for Nunavut, Quebec, and British Columbia). Infoway has also secured partnerships with several distributers. Infoway also continues to develop its ACCESS Health program. It is currently designing two facets of the program: Access Atlantic and Access Gateway. As a part of the ACCESS Health program, Infoway is developing a national trust framework to help protect the privacy and manage the consent of patients.

Expected results
Provincial/territorial governments and stakeholders engaged in expanding digital health technologies; health care providers and patients accessing, and equipped with the knowledge and skills to use, digital health technologies and digital health information; health care providers using digital health technologies to provide more efficient and high quality health care; and patients using digital health technologies to manage and/or improve their health to a modern and sustainable health care system where Canadians have access to appropriate and effective health care.
Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
Infoway is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada works with Infoway to establish activities to be carried out under the Contribution Agreement, and maintains regular contact with Infoway to monitor progress and compliance under the Contribution Agreement.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 75,000,000 77,000,000 80,000,000 0
Total other types of transfer payments 0 0 0 0
Total program 75,000,000 77,000,000 80,000,000 0

Note: Canada Health Infoway is also reported under the “Up-Front Multi-Year Funding” section of the Supplementary Information Tables.

3-year plan for Contribution to the Canadian Agency for Drugs and Technologies in Health

Start date
April 1, 2008
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems
Link to the department’s Program Inventory
Program 2: Access, Affordability, and Appropriate Use of Drugs and Medical Devices
Purpose and objectives of transfer payment program
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent, not-for-profit agency funded by Canadian federal, provincial, and territorial governments to provide credible, impartial and evidence-based information about the clinical/cost-effectiveness and optimal use of drugs and other health technologies to Canadian health care decision makers.
Expected results
The purpose of the contribution agreement is to provide financial assistance to support CADTH's core business activities, namely, the Common Drug Review, Health Technology Assessments and Optimal Use Projects. Results include: the creation and dissemination of evidence-based information that supports informed decisions on the adoption and appropriate utilization of drugs and non-drug technologies, in terms of both effectiveness and cost. Additional funding announced in Budget 2017 is supporting CADTH's ongoing transition to a health technology management organization in order to deliver results that better meet the needs of the healthcare system.
Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
CADTH, an independent, not-for-profit agency is the sole recipient of transfer payment funds.
Initiatives to engage applicants and recipients
Health Canada works with CADTH to establish activities to be carried out under the contribution agreement, and maintains regular contact with CADTH to monitor progress and compliance under the contribution agreement.

CADTH has also produced numerous products and services including health technology reports, optimal use projects, environmental scans, therapeutic reviews and formulary listing recommendations. These deliverables provide guidance and evidence-based information to health care decision-makers regarding the cost-effectiveness and optimal use of health technologies. In particular, the formulary listing recommendations increases transparency across jurisdictions and provides consistency to pharmaceutical reimbursement decisions made by the participating public drug plans.

Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 23,058,769 26,058,769 29,058,769 26,058,769
Total other types of transfer payments 0 0 0 0
Total program 23,058,769 26,058,769 29,058,769 26,058,769

3-year plan for Contribution to the Canadian Institute for Health Information

Start date
April 1, 1999
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 7: Health Information
Purpose and objectives of transfer payment program

The Canadian Institute for Health Information (CIHI) is an independent, not-for-profit organization supported by federal, provincial and territorial governments (FPT) that provides essential data and analysis on Canada's health system and the health of Canadians. CIHI was created in 1994 by the FPT Ministers of Health to address significant gaps in health information.

Between 1994 and 2018, the Government of Canada allocated approximately $1,232 million in total to CIHI through a series of contribution agreements. Under the current agreement signed in early 2018, over $365 million will be delivered to CIHI over 5 years (2017-18 to 2021-22). Presently, Health Canada funds 79% of CIHI's total budget, while the provincial and territorial governments contribute 19%. The remaining funds are generated largely through product sales.

Expected results
This funding allows CIHI to provide essential information on Canada's health care systems and the health of Canadians. CIHI provides comparable and actionable data and information that are used to accelerate improvements in health care, health system performance and population health across the continuum of care. CIHI's stakeholders use the broad range of the Institute's health system databases, measurements and standards, together with their evidence-based reports and analyses, in their decision-making processes. CIHI protects the privacy of Canadians by ensuring the confidentiality and integrity of the health care information they provide.
Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
CIHI is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada works with CIHI to establish activities to be carried out under the contribution agreement, and maintains regular contact with CIHI to monitor progress and compliance under the contribution agreement.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 87,658,979 92,658,979 97,658,979 92,658,979
Total other types of transfer payments 0 0 0 0
Total program 87,658,979 92,658,979 97,658,979 92,658,979

3-year plan for Contribution to the Canadian Partnership Against Cancer

Start date
April 1, 2007
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services.
Link to the department’s Program Inventory
Program 10: Cancer Control
Purpose and objectives of transfer payment program

The Canadian Partnership Against Cancer (CPAC) is an independent, not-for-profit corporation established to implement the Canadian Strategy for Cancer Control (CSCC). The CSCC was developed in consultation with more than 700 cancer experts and stakeholders with the following objectives:

  • Reduce the expected number of new cases of cancer among Canadians;
  • Enhance the quality of life of those living with cancer; and,
  • Lessen the likelihood of Canadians dying from cancer.

Health Canada is responsible for managing the funding to the corporation. CPAC was eligible to receive $250 million from the federal government for its first five-year term (2007 to 2012) and $241 million for its second five-year term (2012 to 2017). Budget 2016 confirmed ongoing funding for CPAC, which is governed by a five-year agreement (2017 to 2022) for $237.5 million.

Expected results

Enhance cancer control through knowledge management and the coordination of efforts among the provinces and territories, cancer experts, stakeholder groups, and Indigenous organizations to champion change, improve health outcomes related to cancer, and leverage existing investments.

A coordinated, knowledge-centered approach to cancer control is expected to significantly reduce the economic burden of cancer, alleviate current pressures on the health care system, and bring together information for all Canadians, no matter where they live.

Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
CPAC is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada works with CPAC to establish activities to be carried out under the contribution agreement, and maintains regular contact with CPAC to monitor progress and compliance under the contribution agreement.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 51,000,000 51,000,000 52,500,000 47,500,000
Total other types of transfer payments 0 0 0 0
Total program 51,000,000 51,000,000 52,500,000 47,500,000

3-year plan for Contribution to the Canadian Patient Safety Institute

Start date
April 1, 2013
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2012-13
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems
Link to the department’s Program Inventory
Program 11: Patient Safety
Purpose and objectives of transfer payment program
The Canadian Patient Safety Institute (CPSI) supports the federal government's interest in achieving an accessible, high quality, sustainable and accountable health system adaptable to the needs of Canadians. It is designed to improve the quality of health care services by providing a leadership role in building a culture of patient safety and quality improvement in the Canadian health care system through coordination across sectors, promotion of best practices, and advice on effective strategies to improve patient safety. CPSI received grant year funding via five-year grant agreements from 2003-2013. A new five-year contribution agreement began on April 1, 2013 and has been extended to March 31, 2021.
Expected results

CPSI provides leadership and coordination of efforts to prevent and reduce harm to patients, with an emphasis on four key areas: safety improvement projects; making patient safety a priority across health care systems; influencing policy, standards, and regulations so that they incorporate best patient safety evidence and practices; and creating and strengthening alliances and networks with partners such as patients, governments, and industry who are committed to making care safer.

Over the coming years, CPSI’s work is expected to contribute to sustained improvements in patient safety across Canada, resulting in reduced incidence rates of preventable harm, and healthier Canadians.

Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
CPSI is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada works with CPSI to establish activities to be carried out under the contribution agreement and maintains regular contact with CPSI to monitor progress and compliance under the contribution agreement.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 7,600,000 7,600,000 7,600,000 7,600,000
Total other types of transfer payments 0 0 0 0
Total program 7,600,000 7,600,000 7,600,000 7,600,000

3-year plan for the Health Care Policy Contribution Program

Start date
September 24, 2002
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2010-11
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 1: Canadians have modern and sustainable health care systems
Result 2: Canadians have access to appropriate and effective health services.
Link to the department’s Program Inventory
Program 1: Health Care Systems Analysis and Policy
Purpose and objectives of transfer payment program
The Health Care Policy Contribution Program (HCPCP) provides up to $26.9 million per fiscal year in time-limited contributionFootnote 1 funding for projects that address specific health care systems priorities, including mental health, home and palliative care, health care systems innovation, and optimization of the health workforce. Through the implementation of contribution agreements and a variety of stakeholder engagement activities, Health Canada contributes to the development and application of effective approaches to support sustainable improvements to health care systems.
Expected results
Program funding will support a wide range of projects designed to ultimately contribute to improvements and transformation in health care systems. For example, health care innovation projects will support activities that develop, implement and evaluate tools, models, and practices that address identified health care systems priorities. Other projects will produce resources that enable health providers to maximize their roles in a range of settings; provide system managers and decision-makers with data and decision-making tools to enhance system planning and performance; and engage key stakeholders in collaborative efforts that contribute to specific health care systems improvements relevant to Program priorities.
Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
Non-profit organizations, other levels of government and other national organizations.
Initiatives to engage applicants and recipients
The Program engages applicants and recipients through discussions on reporting to facilitate the collection of data/information to inform program delivery and results. Recipients are consulted on performance measurement, knowledge translation, and sex and gender based analysis with a view to understanding their needs and the tools they require to meet Program expectations in terms of reporting on results. Training sessions on performance measurement and knowledge translation are available to recipients. Site visits by project officers offer an opportunity to engage recipients in all Program aspects.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 25,543,000 25,568,000 24,403,000 24,403,000
Total other types of transfer payments 0 0 0 0
Total program 25,543,000 25,568,000 24,403,000 24,403,000

3-year plan for Mental Health Commission of Canada Contribution Program

Start date
2000 as a Grant, but as of April 1, 2017 it has become a Contribution.
End date
March 31, 2021
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2018-19
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 4: Mental Health
Purpose and objectives of transfer payment program
The Mental Health Commission of Canada (MHCC), an arm's length, not-for-profit organization, was established in March 2007 with a ten-year mandate to improve health and social outcomes for people and their families living with mental illness. Between 2007 and 2017, the Government of Canada invested $130 million in the MHCC through a grant, to develop a mental health strategy for Canada, conduct an anti-stigma campaign and create a knowledge exchange centre. In 2016, the MHCC's mandate was renewed for a two-year period, from 2017-18 to 2018-19, with a contribution of $14.25 million per year to advance work on mental health priorities, including problematic substance use, suicide prevention, support for at-risk populations and engagement. This contribution has been extended until March 31, 2021.
Expected results
This initiative is expected to contribute to the improved mental health and well-being of Canadians, specifically in the areas of problematic substance use, suicide prevention, and stigma reduction.
Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2023-24
General targeted recipient groups
The MHCC is the sole recipient.
Initiatives to engage applicants and recipients
Regular meetings with the Recipient; analysis and follow-up of progress and financial reporting; and monitoring of performance and results.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 14,250,000 14,250,000 0 0
Total other types of transfer payments 0 0 0 0
Total program 14,250,000 14,250,000 0 0

3-year plan for Official Languages Health Program

Start date
June 18, 2003
End date
March 31, 2022 (Grant)
Ongoing (Contribution)
Type of transfer payment
Grant and Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2018-19
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 13: Promoting Minority Official Languages in the Health Care Systems
Purpose and objectives of transfer payment program
The Official Languages Health Program (OLHP) has a total budget of $191.2 million over five years (2018-2023), and $38.46 million per year ongoing after 2023. The Program supports the federal government's commitment to maintain a strong and effective publicly funded health care system by ensuring that official language minority communities (OLMCs) have access to bilingual health services in the language of their choice. Through the implementation of contribution agreements and micro-grants, Health Canada supports investments that improve the active offer of health services for OLMCs, through training and retention of health care providers, networking activities and innovative projects that increase access to health services for OLMCs.
Expected results
Program funding will support training and retention of health professionals, health networking and innovative projects to improve access to health services for OLMCs. These activities are expected to increase access to bilingual health professionals in OLMCs, and to increase the offer of health services to OLMCs.
Fiscal year of last completed evaluation
2016-17
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2021-22
General targeted recipient groups
Eligible recipients under the program are individuals, non-profit entities, provincially-accredited postsecondary institutions and provincial and territorial government bodies.
Initiatives to engage applicants and recipients
The Program engages recipients, potential recipients and the public in various ways, for example through solicited proposals, through open calls for proposals and through consultation with funding recipients and program stakeholders. Program recipients are also engaged through regular meetings; analysis and follow-up of progress and financial reporting; and monitoring of performance and results.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 50,000 125,000 125,000 0
Total contributions 37,330,000 37,255,000 37,475,000 37,600,000
Total other types of transfer payments 0 0 0 0
Total program 37,380,000 37,380,000 37,600,000 37,600,000

3-year plan for Strengthening Canada's Home and Community Care and Mental Health and Addiction Services Initiative

Start date
November 9, 2017
End date
March 31, 2027
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 3: Home, Community and Palliative Care
Program 4: Mental Health
Purpose and objectives of transfer payment program

The Government of Canada is investing $11 billion over ten years (2017-2027) to support the provinces and territories (PTs) in implementing home care ($6 billion) and mental health and addictions ($5 billion) initiatives in their jurisdictions, in accordance with the Common Statement of Principles for Shared Health Priorities (CSoP) which was jointly agreed to by federal, provincial and territorial (FPT) Ministers of Health (with the exception of Quebec) in August 2017.

In the CSoP, governments agreed to common objectives in each of home and community care and mental health and addiction services, and in particular to improving access to mental health and addictions through one or more of the following areas of action:

  • Expanding access to community-based mental health and addiction services for children and youth (age 10-25), recognizing the effectiveness of early interventions to treat mild to moderate mental health disorders;
  • Spreading evidence-based models of community mental health care and culturally-appropriate interventions that are integrated with primary health services; and,
  • Expanding availability of integrated community-based mental health and addiction services for people with complex health needs.

Similarly, on home and community care, FPT governments agreed to work together to improve access to services through one or more of the following areas of action:

  • Spreading and scaling evidence-based models of home and community care that are more integrated and connected to primary health care;
  • Enhancing access to palliative and end-of-life care at home or in hospices;
  • Increasing support for caregivers; and,
  • Enhancing home care infrastructure, such as digital connectivity, remote monitoring technology and facilities for community based service delivery.

As part of the CSoP, all governments also agreed to develop a focused set of common indicators to measure progress on these priority areas. The Canadian Institute for Health Information (CIHI) led a collaborative process which culminated in May 2018 when federal, provincial and territorial Ministers of Health endorsed a suite of 12 common indicators to be implemented over the coming years. CIHI will continue to work with governments across Canada to report annually on these indicators.

Following agreement by FPT Ministers on a CSoP in 2017, the federal government negotiated and signed the first of two sequential bilateral agreements with all 13 provinces and territories which set out details of how each jurisdiction is using federal investments to improve access to home and community care and mental health and addiction services. The bilateral agreements with the provinces and territories will be renewed starting in 2022-23 for the remaining five years of the ten-year commitment.

Expected results
It is expected that through these investments Canadians will experience tangible improvements in access to home and community care as well as mental health and addictions services. This will lead to better health outcomes and a more sustainable health care system, as care is shifted from expensive hospital care to more patient-centric settings in the home and in the community. These investments could also have a broader, positive impact on Canada's economy, by making the health care system more sustainable in the long term, and by enhancing workforce productivity and social participation.
Fiscal year of last completed evaluation
Not applicable
Decision following the results of last evaluation
Not applicable
Fiscal year of next planned evaluation
2021-22
General targeted recipient groups
Provinces and territories.
Initiatives to engage applicants and recipients

With respect to mental health and addictions, the Government of Canada has engaged with provinces and territories, national Indigenous organizations, mental health stakeholders, provincial and territorial medical associations and treatment centres, and experts.

With respect to the home and community care, the Government of Canada has engaged with a range of home care stakeholders including representatives from national organizations working on home, community and palliative care, provincial home care providers, patient and family advocates, and national health professional associations (e.g., the Canadian Medical Association, Canadian Nurses Association and the College of Family Physicians of Canada), as well as experts.

Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 0 0 0 0
Total other types of transfer payments 1,100,000,000 1,250,000,000 1,500,000,000 1,200,000,000
Total program 1,100,000,000 1,250,000,000 1,500,000,000 1,200,000,000

Note: These amounts will be allocated to provinces and territories on an equal per capita basis based on population estimates from Statistics Canada.

3-year plan for Substance Use and Addictions Program

Start date
December 4, 2014
End date
March 31, 2022 (Grant)
Ongoing (Contribution)
Type of transfer payment
Grants and Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2018-19
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 5: Substance Use and Addictions
Purpose and objectives of transfer payment program
The Substance Use and Addictions Program (SUAP) provides funding for a wide range of evidence-informed and innovative problematic substance use prevention, harm reduction and treatment initiatives across Canada at the community, regional and national levels. Initiatives target a range of psychoactive substances, including opioids, cannabis, alcohol and tobacco. Projects funded by the SUAP contribute to individual capacity and organizational, system and community level program, policy and practice change by: preventing problematic substance use and reducing harms; facilitating treatment service and system enhancements; and, improving awareness, knowledge, skills and competencies of targeted stakeholders and Canadians.
Expected results
Projects funded by the SUAP are expected to contribute to individual capacity and organizational, system and community level program, policy and practice change by: preventing problematic substance use and reducing harms; facilitating treatment and related system enhancements; and, improving awareness, knowledge, skills and competencies of targeted stakeholders and Canadians.
Fiscal year of last completed evaluation
2017-18
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
2021-22
General targeted recipient groups
Community-based, regional and national non-profit organizations, including those in the health and education sectors; and, other levels of government and their agencies.
Initiatives to engage applicants and recipients
Applicants and recipients are engaged through: stakeholder outreach; solicitation processes; project development discussion; and performance reporting and monitoring tools, processes and activities. The Program also supports knowledge translation and exchange opportunities between projects, Health Canada and other partners and stakeholders.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 200,000 200,000 200,000 0
Total contributions 52,044,490 81,742,779 73,139,607 59,586,977
Total other types of transfer payments 0 0 0 0
Total program 52,244,490 81,942,779 73,339,607 59,586,977

3-year plan for Territorial Health Investment Fund

Start date
April 1, 2014
End date
March 31, 2021
Type of transfer payment
Grant
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 16: The Territorial Health Investment Fund
Purpose and objectives of transfer payment program

Building on an initial investment of $70 million (2014-15 to 2017-18), which flowed as contribution funding, the Territorial Health Investment Fund (THIF) was renewed as a grant program in 2017-18 with an additional $108 million over four years (2017-18 to 2020-21). Of this funding, $54 million will be allocated to Nunavut, $28.4 million to Northwest Territories and $25.6 million to Yukon. This funding will enable each territory to continue pursuing innovative activities in support of strong, sustainable health systems and to offset costs associated with medical travel to support Northerners' access to the health care they need.

The use of grant agreements rather than contribution agreements for the new investment will minimize the administrative burden on territories associated with participating in the program.

Expected results
THIF supports territorial efforts to innovate and transform their health care systems and help offset costs associated with medical travel. The expected results for Northerners are: improved access to health care services; health care needs being met; and improved health status.
Fiscal year of last completed evaluation
2018-19
Decision following the results of last evaluation
Continuation
Fiscal year of next planned evaluation
No planned evaluations at this time.
General targeted recipient groups
Territorial governments (Government of the Northwest Territories, Government of Yukon, Government of Nunavut).
Initiatives to engage applicants and recipients
Health Canada worked with territorial governments to establish four-year work plans for use of the grant funding and to secure grant agreements. Health Canada receives annual updates on planned activities from the territorial governments (including through a Federal/Territorial Assistant Deputy Minister Working Group, which will facilitate learning and information sharing across governments). Health Canada will work with territorial governments throughout the life of the agreements to monitor progress and compliance under the grant agreements.
Planning information (dollars)
Type of transfer payment 2019–20
Forecast spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 27,000,000 27,000,000 0 0
Total contributions 0 0 0 0
Total other types of transfer payments 0 0 0 0
Total program 27,000,000 27,000,000 0 0

Transfer Payment Programs under $5 Million

3-year plan for Climate Change and Health Adaptation Capacity Building Program

Start date
April 1, 2018
End date
2020-21 (Grant)
2021-22 (Contribution)
Type of transfer payment
Grant and Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2017-18
Link to the departmental result(s)
Core Responsibility 2: Health Protection and Promotion
Result 4: Canadians are protected from unsafe consumer and commercial products and substances
Link to the department’s Program Inventory
Program 23: Climate Change
Purpose and objectives of transfer payment program
To protect and improve the health of Canadians in a changing climate through better understanding of risks and effective adaptation measures, and by building needed capacity to implement them.

The contributions are not repayable.

Expected results
Health system actors take adaptation measures to reduce the health effects of climate change.

This expected result will be measured by the following indicator:

Percentage of funded health system actors that have taken evidence-based adaptation measures to reduce the health effects of climate change

Target: 80% by March 31, 2022
Fiscal year of last completed evaluation
Not applicable
Decision following the results of last evaluation
Not applicable
Fiscal year of planned completion of next evaluation
2020-21
General targeted recipient groups
Provincial and territorial ministries of health; and established province-wide, regional and local health authorities and public health units.
Initiatives to engage applicants and recipients

Health Canada shared information regarding the launch of the call for proposal with eligible applicants, and regularly communicates with funding recipients regarding the progress of their projects. These engagement activities support the design and delivery of the most effective and efficient evidence-based adaptation measures, and ensures meaningful evaluations in support of future efforts.

Of particular note, the HealthADAPT program supports the engagement of applicants and recipients, through which the Department provides scientific help, training and information exchange that allows for further collaboration opportunities in support of their proposals and projects.

Financial information (dollars)
Type of transfer payment 2019–20
Planned spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 78,000 0 0
Total contributions 1,220,438 1,422,000 1,200,000 0
Total other types of transfer payments 0 0 0 0
Total program 1,220,438 1,500,000 1,200,000 0

3-year plan for Contribution to Strengthen Canada's Organs and Tissues Donation and Transplantation System

Start date
April 1, 2008
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2013-14
Link to the departmental result(s)
Core Responsibility 1: Health Care Systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 12: Organs, Tissues and Blood
Purpose and objectives of transfer payment program
To support the development of a national organ and tissue donation and transplantation system that will improve and extend the quality of the lives of Canadians while respecting the federal role and interest in organ and tissue donation and transplantation. The current agreement ends in 2020-21.
Expected results
The Canadian Blood Services (CBS) – Organ and Tissue Donation and Transplantation Program is expected to generate knowledge products and a learning event during that year. The Program is expected to identify leading practices and make recommendations for next steps in the area of living and deceased donations. It will also lead to the implementation of a professional education on-line donor management module.
Fiscal year of last completed evaluation
2017-18
Decision following the results of last evaluation
Continuation
Fiscal year of planned completion of next evaluation
2022-23
General targeted recipient groups
Canadian Blood Services is the sole recipient.
Initiatives to engage applicants and recipients
Health Canada officials undertake numerous exchanges (e.g., meetings, phone calls, e-mails and knowledge transfer activities) with CBS program staff and senior management to discuss program progress. In addition, Health Canada continues to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance and financial reporting.
Financial information (dollars)
Type of transfer payment 2019–20
Planned spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 3,580,000 3,580,000 3,580,000 3,580,000
Total other types of transfer payments 0 0 0 0
Total program 3,580,000 3,580,000 3,580,000 3,580,000

3-year plan for Innovative Solutions Canada

Start date
August 23, 2019
End date
March 31, 2023
Type of transfer payment
Grant
Type of appropriation
Estimates
Fiscal year for terms and conditions
2019-20
Link to the departmental results
Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems
Result 2: Canadians have access to appropriate and effective health services
Link to the department’s Program Inventory
Program 1: Health Care System Analysis and Policy
Purpose and objectives of transfer payment program
Innovative Solutions Canada is a horizontal Government of Canada initiative, coordinated by Innovation Science and Economic Development Canada, in which participating departments and agencies can issue challenges to Canadian businesses to develop solutions for operational or sector-specific issues and fund the early stage research and development of these innovations. Health Canada’s participation will enable innovators and entrepreneurs to generate novel solutions to help Canadians maintain and improve their health.
Expected results

Health Canada’s participation will contribute to the short, medium and long-term results and outcomes of the Innovative Solutions Canada program. These include the generation of new Canadian Intellectual Property, commercialization of early stage research and development, and increasing the employment of highly skilled workers in the Canadian innovation ecosystem.

Results will be reported under Innovation, Science and Economic Development Canada’s monitoring and evaluation processes which encompass the entirety of the Innovative Solutions Canada program, including Health Canada’s participation therein.

Fiscal year of last completed evaluation
Not applicable
Decision following the results of last evaluation
Not applicable
Fiscal year of planned completion of next evaluation
TBD
General targeted recipient groups
For-profit organizations
Initiatives to engage applicants and recipients
Not applicable. As a horizontal initiative, Innovation, Science and Economic Development Canada will lead engagement with applicants and recipients of funding under Innovative Solutions Canada.
Planning information (dollars)
Type of transfer payment 2019–20
Planned spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 1,400,000 1,400,000 1,400,000 1,400,000
Total contributions 0 0 0 0
Total other types of transfer payments 0 0 0 0
Total program 1,400,000 1,400,000 1,400,000 1,400,000

3-year plan for Radon Outreach Contribution Program

Start date
April 1, 2018
End date
Ongoing
Type of transfer payment
Contribution
Type of appropriation
Estimates
Fiscal year for terms and conditions
2018-19
Link to the departmental result(s)
Core Responsibility 2: Health Protection and Promotion
Result 4: Canadians are protected from unsafe consumer and commercial products and substances
Link to the department’s Program Inventory
Program 31: Radiation Protection
Purpose and objectives of transfer payment program

To protect and improve human health and well-being in Canada from the impacts of indoor radon exposure, by aiding in the education of Canadians about the importance of testing their homes, schools and workplaces for radon and reducing the radon levels where necessary.

The contributions are not repayable.

Expected results
The expected results are:
  • Canadians are aware of radon; and
  • Canadians change behaviour to reduce exposure to radon.

These expected results will be measured by the following indicators:

Percentage of Canadians surveyed who are knowledgeable about radon
Target: 65% by March 31, 2021

Percentage of Canadian homeowners surveyed who have tested their homes for radon
Target: 10% by March 31, 2026

Fiscal year of last completed evaluation
Not applicable
Decision following the results of last evaluation
Not applicable
Fiscal year of next planned evaluation
2020-21
General targeted recipient groups
Regional and local governments, including local health authorities; not-for-profit organizations (including voluntary organizations); professional associations; national Indigenous organizations; and educational institutions.
Initiatives to engage applicants and recipients
Radon Outreach Contribution Program applicants and recipients are engaged and consulted through face-to-face meetings at relevant conferences and workshops and by email and telephone. Applicant and recipient consultations are structured to support them in designing programs to maximize reach and impact and provide expertise and support throughout the delivery and evaluation of their programs with an overarching goal of raising awareness and promoting action to reduce radon-induced lung cancer in Canada.
Financial information (dollars)
Type of transfer payment 2019–20
Planned spending
2020–21
Planned spending
2021–22
Planned spending
2022–23
Planned spending
Total grants 0 0 0 0
Total contributions 200,000 250,000 250,000 250,000
Total other types of transfer payments 0 0 0 0
Total program 200,000 250,000 250,000 250,000

Horizontal Initiatives

Addressing the Opioid Crisis

General information

Name of horizontal initiative
Addressing the Opioid Crisis
Lead department
Health Canada
Federal partner organization(s)

Canada Border Services Agency
Public Health Agency of Canada
Public Safety Canada
Statistics Canada

Note: Other government departments (e.g., Correctional Service Canada) are supporting the federal response to the overdose crisis. However, they are not captured in this Horizontal Initiative table, as they have not received funding through the Treasury Board Submission “Addressing the Opioid Crisis.”

Start date
April 1, 2018
End date
March 31, 2023 and ongoing
Description

Illegal drugs and problematic substance use have always presented health and safety challenges in Canada and around the world. Recently, however, there has been a dramatic rise in the number of opioid-related overdoses and deaths. The people most affected in this overdose crisis continue to be young to middle-aged individuals and men, whose deaths are mostly accidental and largely due to the contamination of the illegal drug supply with highly toxic fentanyl and/or fentanyl analogues. The scale of this crisis is so severe that life expectancy in Canada has stopped increasing for the first time in over 40 years. Fentanyl is a cheap way for drug dealers to make street drugs more powerful and it is causing high rates of overdoses and overdose deaths. A few grains can be enough to cause a fatal overdose.

The federal government’s actions to address the overdose crisis are guided by the Canadian Drugs and Substances StrategyFootnote 5, which takes a comprehensive, collaborative, and compassionate approach to substance use issues using a public health lens. The federal government is deeply concerned about the number of overdoses and deaths, and is taking significant actions in areas of federal jurisdiction to address the crisis. However, despite significant efforts to date, the overdose crisis in Canada continues. According to data from the Public Health Agency of Canada, more than 13,913 people lost their lives in Canada between January 2016 and June 2019 to apparent opioid-related overdoses. In addition, it is estimated that approximately 250,000 Canadians do not have access to treatment when seeking help for problematic substance use. Since people who use drugs have traditionally been stigmatized, Canadians struggling with substance use disorder often encounter barriers when accessing health, medical and social services.

While the Government of Canada is taking a number of actions to respond to the overdose crisis, this horizontal initiative is specific to measures announced in Budget 2018 to:

  • support additional prevention and treatment interventions through an expansion of the Substance Use and Addictions Program (SUAP);
  • address the stigma surrounding people who use drugs, which creates barriers for those seeking treatment, through a public education campaign and training for law enforcement;
  • enhance capacity to identify and intercept illegal substances at the border by equipping border agents with additional tools at ports of entry; and,
  • improve the availability of and access to public health data by expanding public health surveillance, conducting special studies, and redesigning the Canadian Coroner and Medical Examiner Database (CCMED).

Ultimately, these complementary activities are intended to contribute to a reduction in overdose harms and deaths in Canada.

Governance structure

The Government of Canada has put in place a robust governance structure to facilitate whole-of-government coordination in implementing a comprehensive federal response to the overdose crisis. Each department/agency will be responsible for leading its respective initiatives and providing updates to the interdepartmental Assistant Deputy Minister (ADM) level Working Group on Opioids chaired by the Associate-ADM of Health Canada’s Controlled Substances and Cannabis Branch. This working group is used as a forum for information and consultation on next steps toward a comprehensive, collaborative federal response to the overdose crisis. Updates and decisions from this working group feed into the federal, interdepartmental Deputy Ministers Task Force on the Opioid Crisis as required. This Task Force, chaired by the Deputy Minister of Health Canada, serves as a time-limited forum to provide leadership and oversight of federal initiatives to respond to the overdose crisis. The Task Force will remain an established committee until such time that the public environment no longer requires it.

The Government is committed to ongoing collaboration and consultation with provincial and territorial partners. Departments and agencies will provide updates to, and consult with, provincial and territorial colleagues as required through the federal/provincial/territorial (FPT) ADM-level Problematic Substance Use and Harms Committee (PSUH), co-chaired by Health Canada and British Columbia and comprised of ADMs responsible for drug policy in their jurisdiction. They will also provide updates to and consult with PT colleagues as required through the FPT Special Advisory Committee on the Epidemic of Opioid Overdoses (SAC), co-chaired by the Chief Public Health Officer of Canada and Saskatchewan’s Chief Medical Officer of Health and comprising Chief Medical Officers of Health from each jurisdiction. While the PSUH is an established committee intended as a long-term forum for drug policy discussions, the SAC is a time-limited mechanism for public health collaboration and information sharing between jurisdictions related to the overdose crisis in Canada. Efforts are underway to transition activities of the SAC that require ongoing FPT collaboration to permanent structures, either under the PSUH or the Pan-Canadian Public Health Network (PHN).

Total federal funding allocated from start to end date (dollars)
$ 108,794,404 (includes existing funding)
Total federal planned spending to date (dollars)
$21,467,133
Total federal actual spending to date (dollars)
$13,855,443
Date of last renewal of initiative
Not applicable
Total federal funding allocated at last renewal and source of funding (dollars)
Not applicable
Additional federal funding received after last renewal (dollars)
Not applicable
Total planned spending since last renewal
Not applicable
Total actual spending since last renewal
Not applicable
Fiscal year of planned completion of next evaluation
2021-22

Planning highlights

All federal partners will work collaboratively to address the overdose crisis in a comprehensive, robust, and effective manner. Planning highlights specific to this horizontal initiative in 2020-21 will include:

Contact information

Health Canada
Jennifer Novak
Acting Director General
Controlled Substances and Cannabis Branch
Jennifer.Novak@canada.ca
613-946-8099

Horizontal initiative framework: departmental funding by theme (dollars)

Horizontal initiative: Addressing the Opioid Crisis

Shared outcome: Reducing harms and deaths related to opioid use
Name of theme Theme Area 1: Supporting additional prevention and treatment interventions Theme Area 2: Addressing stigma Theme Area 3:
Taking Action at Canada's Borders
Theme Area 4: Enhancing the Evidence Base Internal Services

Theme outcome(s)

Targeted stakeholdersTable 20 Footnote 1 use evidence-informed informationTable 20 Footnote 2 on opioid use to change policies, programs, and practice

Increased perception among Canadians of drug use as a public health issue

Enhanced capability to interdict illegal cross-border movement of drugs, such as opioids, at ports of entry

Enhanced quality surveillanceTable 20 Footnote 3 data is available

Not applicable

Health Canada

  • $13,169,264 (Top- up)
  • $13,000,000 (Existing)
  • $7,030,966 (Ongoing)
  • $12,456,900 (Top-up)
  • $10,234,157 (Existing)
  • $2,724,238 (Ongoing)

Not applicable

Not applicable

  • $873,836 (Top-up)
  • $599,273 (Existing)
  • $253,796 (Ongoing)

Canada Border Services Agency

Not applicable

Not applicable

  • $30,254,740
  • $4,716,380 Ongoing

Not applicable

  • $3,125,260
  • $664,620 Ongoing

Public Health Agency of Canada

Not applicable

Not applicable

Not applicable

Enhancing surveillance

  • $14,928,466 (Top-up)
  • $1,419,856 (Existing)
  • $1,780,979 (Ongoing)
  • $971,534
  • $114,375 Ongoing

Public Safety Canada

Not applicable

  • $801,132 (Top-up)
  • $1,038,870 (Existing)
  • $3,204,529 (Top-up)
  • $115,430 (Existing)

Not applicable

  • $460,812 (Top-up)
  • $145,453 (Existing)

Statistics Canada

Not applicable

Not applicable

Not applicable

  • $1,905,286
  • $226,195 Ongoing
  • $89,606
  • $16,251 Ongoing
Table 20 Footnote 1

Targeted stakeholders will differ by individual project funded by the SUAP but may include: other levels of government, pan-Canadian health organizations, non-profit organizations, communities or others at the organizational or system level. This target population category relates to initiatives targeting organization, system or policy and practice change.

Table 20 Return to footnote 1 referrer

Table 20 Footnote 2

Evidence-informed information is evidence from research, practice and experience used to inform and improve opioid related policy, programs, practice and behaviour (e.g., curriculum, reports, guidelines, literature, and program materials).

Table 20 Return to footnote 2 referrer

Table 20 Footnote 3

Public health surveillance is the continuous, systematic collection, analysis and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice. In the context of opioid-related harms, this involves collecting data on health outcomes/events, including suspected overdoses and deaths, socio-demographic variables and risk factors.

Table 20 Return to footnote 3 referrer

Planning information

Horizontal initiative overview
Name of horizontal initiative Total federal funding allocated since the last renewal
(dollars)
2020-21 Planned spending
(dollars)
Horizontal initiative shared outcome(s) Performance indicator(s) Target(s) Date to achieve target

Addressing the Opioid Crisis

  • HC:
    $ 50,333,430
  • CBSA:
    $33,380,000
  • PHAC:
    $ 17,319,856
  • PS:
    $ 5,766,226
  • StatCan:
    $1,994,892
  • HC:
    $9,009,000
  • CBSA:
    $5,313,000
  • PHAC:
    $ 4,971,848
  • PS:
    $1,018,563
  • StatCan:
    $480,000

Reduced harms and deaths related to opioid use.

Number of hospital admissions due to opioid poisoning (including overdoses) per 100,000 population (by gender, age, region)
Number of apparent opioid-related deaths per 100,000 population (by gender, age, region)

% reductionTable 21 Footnote 1

March 31, 2021

Table 21 Footnote 1

Decrease in baseline year over year to 2021. Baseline for hospital admissions: 16.4 per 100,000 population in 2017. Baseline for apparent opioid-related deaths: 10.9 per 100,000 population in 2017.

Table 21 Return to footnote 1 referrer

Theme 1 details
Name of theme Total federal theme funding allocated since the last renewal (dollars) 2020–21 Federal theme planned spending (dollars) Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 1: Supporting Additional Prevention and Treatment Interventions HC:
$ 26,169,264
HC:
$ 6,039,542
Targeted stakeholdersTable 22 Footnote 1 use evidence-informed informationTable 22 Footnote 2 on opioid use to change policies, programs, and practice Percentage of targeted stakeholders reporting that they made evidence informed improvements to opioid use policies, programs and practice (by type of improvementTable 22 Footnote 3) The department continues to identify an appropriate indicator, target and target date. It is anticipated that this work will be completed by Spring 2020. The department continues to identify an appropriate indicator, target and target date. It is anticipated that this work will be completed by Spring 2020.
Table 22 Footnote 1

Targeted stakeholders will differ by individual project funded by the SUAP but may include: other levels of government, pan-Canadian health organizations, non-profit organizations, communities or others at the organizational or system level. This target population category relates to initiatives targeting organization, system or policy and practice change.

Table 22 Return to footnote 1 referrer

Table 22 Footnote 2

Evidence-informed information is evidence from research, practice and experience used to inform and improve opioid related policy, programs, practice and behaviour (e.g., curriculum, reports, guidelines, literature, program materials).

Table 22 Return to footnote 2 referrer

Table 22 Footnote 3

Types of improvement is a reference to data that will be submitted to Health Canada by funded SUAP projects broken down by policy, program or practice change. Examples could include adopting policies to ensure the meaningful involvement of people with lived experience; changes to programs to make them more culturally relevant or trauma-informed; and practice changes that improve treatment service such as adopting current national opioid treatment guidelines.

Table 22 Return to footnote 3 referrer

Theme 1 horizontal initiative activities
Departments Link to the department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since the last renewal (dollars) 2020–21 Planned spending for each horizontal initiative activity (dollars) 2020–21 Horizontal initiative activity expected result(s) 2020–21 Horizontal initiative activity performance indicator(s) 2020–21 Horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Substance Use and Addictions Expanded contribution funding $ 26,169,264 $ 6,039,542 ER 1.1.1 PI 1.1.1 T 1.1.1 The department continues to identify an appropriate indicator, target and target date. It is anticipated that this work will be completed by Spring 2020.
ER 1.1.2 PI 1.1.2 T 1.1.2
Theme 2 details
Name of theme Total federal theme funding allocated since the last renewal (dollars) 2020–21 Federal theme planned spending (dollars) Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target

Theme Area 2: Addressing Stigma

  • HC:
    $ 22,691,057
  • PS:
    $1,840,002

Increased perception among Canadians of drug use as a public health issue

Percentage of Canadians who believe that the opioid crisis in Canada is a public health issue

Increase by 5 percentage pointsTable 24 Footnote 2

March 31, 2021

Table 24 Footnote 1

Total funding includes Salary, O&M, G&C and centrally held funds used to support this theme. Internal services cost are not included in this amount.

Table 24 Return to footnote 1 referrer

Table 24Footnote 2

Baseline: 74% in 2017

Table 24 Return to footnote 2 referrer

Theme 2 horizontal initiative activities
Departments Link to the department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since the last renewal (dollars) 2020–21 Planned spending for each horizontal initiative activity (dollars) 2020–21 Horizontal initiative activity expected result(s) 2020–21 Horizontal initiative activity performance indicator(s) 2020–21 Horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Controlled Substances Public education campaign $ 22,691,057 $ 2,723,499 ER 2.1.1 PI 2.1.1 T 2.1.1 March 31, 2020
ER 2.1.2 PI 2.1.2 T 2.1.2 March 31, 2021
Public Safety Countering Crime De-stigmatization awareness training for law enforcement $1,840,002 $240,952 ER 2.2 PI 2.2 T 2.2 March 31, 2020
Theme 3 details
Name of theme Total federal theme funding allocated since the last renewal (dollars) 2020–21 Federal theme planned spending (dollars) Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target

Theme Area 3: Taking Action at Canada’s Borders

  • PS:
    $3,319,959
  • CBSA:
    $30,254,740

Enhanced capability to interdict illegal cross-border movement of drugs, such as opioids, at ports of entry

Percentage of interdictions of drugs, including opioids, using detector dogs (compared to random resultant rate)

A target will be established in 2021-22, once a baseline has been established. The objective will be to maintain or exceed previous years’ results

March 31, 2021

Percentage of interdictions of drugs, including opioids, resulting from targeted examinations (compared to random resultant rate)

Table 26 Footnote 1

Total funding includes Salary, O&M, G&Cs and centrally held funds used to support this theme. Internal services cost are not included in this amount.

Table 26 Return to footnote 1 referrer

Theme 3 horizontal initiative activities
Departments Link to the department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since the last renewall (dollars) 2020–21 Planned spending for each horizontal initiative activity (dollars) 2020–21 Horizontal initiative activity expected result(s) 2020–21 Horizontal initiative activity performance indicator(s) 2020–21 Horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Public Safety Countering Crime Information sharing with law enforcement and international partners $3,319,959 $663,805 ER 3.1 PI 3.1 T 3.1 March 31, 2020
Canada Border Security Agency Commercial-Trade
Facilitation and Compliance
Equipping safe examination areas and regional screening facilities $1,638,673 $216,960 ER 3.2.1 PI 3.2.1.1 T 3.2.1.1 March 31, 2020
Force Generation $2,153,613 $386,430
Buildings and Equipment $11,353,992 $512,201
Field Technology Support $7,951,329 $2,168,392 PI 3.2.1.2 T 3.2.1.2 March 31, 2023
PI 3.2.1.3 T 3.2.1.3 March 31, 2020
Targeting Augmenting intelligence and risk assessment capacity $2,041,704 $296,038 ER 3.2.2 PI 3.2.2 T 3.2.2 March 31, 2021
Intelligence Collection and Analysis $3,284,279 $660,198 ER 3.2.3 PI 3.2.3 T 3.2.3 March 31, 2023
Commercial-Trade Facilitation and Compliance Enhancement of Detector Dog Program $1,831,150 $254,780 ER 3.2.4 PI 3.2.4.1 T 3.2.4.1 March 31, 2021
PI 3.2.4.2 T3.2.4.2 March 31, 2021
Theme 4 details
Name of theme Total federal theme funding allocated since the last renewal (dollars) 2020–21 Federal theme planned spending (dollars) Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target

Theme Area 4: Enhancing the Evidence Base

  • PHAC:
    $ 16,348,322
  • StatCan:
    $1,905,286
  • PHAC:
    $ 4,681,715
  • StatCan:
    $462,579

Enhanced quality surveillanceTable 28 Footnote 1 data is available

Number of opioid-related evidence productsTable 28 Footnote 2 disseminated publicly

11

March 31, 2020

Percentage of data files published on time

100%

March 31, 2020

Table 28 Footnote 1

Public health surveillance is the continuous, systematic collection, analysis and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice. In the context of opioid-related harms, this involves collecting data on health outcomes/events, including suspected overdoses and deaths, socio-demographic variables and risk factors.

Table 28 Return to footnote 1 referrer

Table 28 Footnote 2

Includes national reports, peer-reviewed (scientific) journal articles, infographics, factsheets, and related analytical products.

Table 28 Return to footnote 2 referrer

Theme 4 horizontal initiative activities
Departments Link to the department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since the last renewal (dollars) 2020–21 Planned spending for each horizontal initiative activity (dollars) 2020–21 Horizontal initiative activity expected result(s) 2020–21 Horizontal initiative activity performance indicator(s) 2020–21 Horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Public Health Agency of Canada Evidence for Health Promotion, and Chronic Disease and Injury Prevention Expansion of public health surveillance $16,348,322 $ 4,681,715 ER 4.1 PI 4.1 T 4.1 March 31, 2020
Statistics Canada Socio-economic Statistics Re-design and operation of the Canadian Coroner and Medical Examiner Database (CCMED) $1,905,286 $ 462,579 ER 4.2 PI 4.2 T 4.2 TBC when target is established in March 2020
Total spending, all themes
Theme Total federal funding allocated since the last renewal
(dollars)
2020–21 Total federal planned spending
(dollars)
Theme 1 $ 26,169,264 [ $6,039,542 ]
Theme 2 $ 24,531,059 [ $2,964,451 ]
Theme 3 $33,574,699 [ $5,158,804 ]
Theme 4 $ 18,253,608 [ $5,144,294 ]
Total, all themes $102,528,630 [$19,307,091]

Theme 1: Supporting Additional Prevention and Treatment Interventions

Expected results

Health Canada

Performance indicators

Health Canada

Targets

Health Canada

Theme 2: Addressing Stigma

Expected results

Health Canada

Public Safety Canada

Performance indicators

Health Canada

Public Safety Canada

Targets

Health Canada

Public Safety Canada

Theme 3: Taking Action at Canada’s Borders

Expected results

Public Safety Canada

Canada Border Services Agency

Performance indicators

Public Safety Canada

Canada Border Services Agency

Targets

Public Safety Canada

Canada Border Services Agency

Theme 4: Enhancing the Evidence Base

Expected results

Public Health Agency of Canada

Statistics Canada

Performance indicators

Public Health Agency of Canada

Statistics Canada

Targets

Public Health Agency of Canada

Statistics Canada

Canadian Drugs and Substances Strategy

General information

Name of horizontal initiative
Canadian Drugs and Substances Strategy
Lead department
Health Canada
Federal partner organization(s)
Canada Border Services Agency
Canada Revenue Agency
Canadian Institutes of Health Research
Correctional Service Canada
Department of Justice Canada
Financial Transactions and Reports Analysis Centre of Canada
Global Affairs Canada
Indigenous Services Canada
Parole Board of Canada
Public Health Agency of Canada
Public Prosecution Service of Canada
Public Safety Canada
Public Services and Procurement Canada
Royal Canadian Mounted Police
Start date
April 1, 2017
End date
March 31, 2022 and ongoing
Description

The Government of Canada is committed to a comprehensive, collaborative, compassionate and evidence-based approach to drug policy, which uses a public health lens when considering and addressing problematic substance use. The Canadian Drugs and Substances Strategy (CDSS) is led by the Minister of Health, supported by Health Canada and 14 other federal departments and agencies. The CDSS covers a broad range of legal and illegal substances, including cannabisFootnote 12, alcohol, opioidsFootnote 13 and other kinds of substances that can be used problematically. The goal of the strategy is to protect the health and safety of all Canadians by minimizing harms from substance use for individuals, families and communities.

The CDSS formally restores harm reduction as a pillar of federal drug and substance use policy, alongside the existing prevention, treatment and enforcement pillars, supported by a strong, modern evidence base across all pillars. The public health focus on the CDSS, along with the inclusion of harm reduction as a core pillar of the strategy, will better enable the Government to address the current opioid crisis, and to work toward preventing the emergence of new challenges in substance use.

The CDSS recognizes that the national approach to substance use requires coordinated efforts from all levels of government working in their respective areas of jurisdiction. It also recognizes the importance of incorporating stakeholder views on an ongoing basis, including people with lived and living experience with substance use. Reducing the stigma experienced by people who use drugs is also integral to the CDSS and a priority for the Government of Canada.

Governance structure

The CDSS is led by the Minister of Health. The Strategy is coordinated through a Director-General (DG) level steering committee that reports to Assistant Deputy Ministers (ADMs).

The DG Steering Committee is designed to reflect and support the CDSS’s comprehensive approach to drug and substance use issues. The committee is composed of DGs from federal departments/agencies whose mandates are relevant to drug and substance use (including departments that formally receive CDSS funding and those that do not). The Committee, which meets at least twice a year and also on an ad hoc basis, is supported by three working groups:  the Demand and Harm Reduction Working Group; the Supply Reduction Working Group; and the Evaluation and Reporting Working Group.

Current federal/provincial/territorial (F/P/T) engagement is achieved through a number of F/P/T mechanisms, including the F/P/T Committee on Problematic Substance Use and Harms that is co-chaired by HC and the Province of British Columbia. Secretariat support for the CDSS is provided by the Controlled Substances Directorate (CSD) within HC.

Total federal funding allocated (2017-18 to 2021-22) (dollars)
$642,844,373
Total federal planned spending to date (dollars)
$260,759,664
Total federal actual spending to date (dollars)
$305,582,320
Date of last renewal of initiative
Not applicable
Total federal funding allocated at last renewal and source of funding (dollars)
Not applicable
Additional federal funding received after last renewal (dollars)
Not applicable
Total planned spending since last renewal
Not applicable
Total actual spending since last renewal
Not applicable
Fiscal year of planned completion of next evaluation
2021-22

Planning highlights (for 2020-21)

Contact information

Health Canada

Michelle Boudreau
Director General
Controlled Substances Directorate
Michelle.Boudreau@canada.ca
613-960-2496

Horizontal initiative framework: departmental funding by theme (dollars)

Horizontal initiative: Canadian Drugs and Substances Strategy

Shared outcomes:

Name of theme Theme Area 1:
Prevention
Theme Area 2:
Treatment
Theme Area 3:
Harm Reduction
Theme Area 4:
Enforcement
Theme Area 5:
Evidence Base
Internal Services
Theme outcome(s) Preventing problematic substance use – note Health Canada is continuing to work with the other federal CDSS partners to review and update the prevention theme outcomes Supporting access to treatment services – note Health Canada is continuing to work with the other federal CDSS partners to review and update the treatment theme outcomes Reduction in risk-taking behaviour among people with problematic drug or substance use Law enforcement and drug regulation activities – note Health Canada is continuing to work with the other federal CDSS partners to review and update the enforcement theme outcomes Data and research evidence on drugs, and emerging drug trends, are used by members of the federal Health Portfolio and their partners Not applicable
Health CanadaFootnote 1 $130,490,598 Footnote 2 Not applicable $18,415,181Footnote 3 Footnote 4 $94,799,995 $8,520,776 $5,117,712Footnote 5
Canada Border Services Agency Not applicable Not applicable Not applicable $11,500,000 Not applicable $6,500,000
Canada Revenue Agency Not applicable Not applicable Not applicable $4,209,225 Not applicable $790,775
Canadian Institutes of Health Research Not applicable $6,874,990 Not applicable Not applicable $10,000,000 Not applicable
Correctional Services Canada Not applicable Not applicable Not applicable $9,258,480 Not applicable Not applicable
Department of Justice Canada Not applicable $26,479,177 Not applicable Not applicable Not applicable $42,375
Financial Transactions and Reports Analysis Centre of Canada Not applicable Not applicable Not applicable $0 Not applicable Not applicable
Global Affairs Canada Not applicable Not applicable Not applicable $4,500,000 Not applicable Not applicable
Indigenous Services Canada $14,376,000 $60,357,585 $15,000,000 Not applicable Not applicable Not applicable
Parole Board of Canada Not applicable Not applicable Not applicable $7,695,000 Not applicable $1,710,000
Public Health Agency of Canada Not applicable Not applicable $30,000,000 Not applicable $844,603 $55,397
Public Prosecution Service of Canada Not applicable Not applicable Not applicable $53,196,935 Not applicable $7,803,065
Public Safety Canada Not applicable Not applicable Not applicable $2,942,660 Not applicable $75,710
Public Services and Procurement Canada Not applicable Not applicable Not applicable $3,000,000 Not applicable Not applicable
Royal Canadian Mounted Police $11,110,528 Not applicable Not applicable $82,663,397 Not applicable $14,514,209
Footnote 1

Health Canada Internal Services include $2,436,740 for the Lead Role.

Return to footnote 1 referrer

Footnote 2

The Substance Use and Addictions Program (SUAP) consolidated funding is reported under the Prevention theme and continues to contribute to both the Prevention and Treatment themes.

Return to footnote 2 referrer

Footnote 3

The Total Allocation Funding for the Substance Use and Addictions Program (SUAP) for Harm Reduction and Evidence Base activities has been decreased to $130,490,598 as $1,164,430 has been reallocated through the 2018-19 Addressing the Opioid Crisis submission. The Expected Results, Performance Indicators and Targets have been removed.

Return to footnote 3 referrer

Footnote 4

The Total Allocation Funding for Strengthening the CDSS has decreased to $18,415,181 as $17,276,836 has been reallocated through the 2018-19 Addressing the Opioid Crisis submission.

Return to footnote 4 referrer

Footnote 5

The Total Allocation Funding for Internal Services has decreased to $5,117,712 as $481,164 has been reallocated through the 2018-19 Addressing the Opioid Crisis submission.

Return to footnote 5 referrer

Planning information

Horizontal initiative overview
Name of horizontal initiative Total federal funding allocated since last renewal
(dollars)
2020–21 planned spending
(dollars)
Horizontal initiative shared outcome(s) Performance indicator(s) Target(s) Date to achieve target
Canadian Drugs and Substances Strategy (CDSS)Footnote 1 $642,844,373 $133,465,475 Health Canada is working with the other federal CDSS partners to update the shared outcome(s) Health Canada is working with the other federal CDSS partners to review and update the shared performance indicator(s) TBD TBD
Footnote 1

Funding includes internal services and lead role.

Return to footnote 1 referrer

Theme 1 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 1:
Prevention
$155,977,126 $36,798,669 Health Canada is working with the other federal CDSS partners to update the shared outcome(s) Health Canada is working with the other federal CDSS partners to review and update the performance indicator(s) for this theme TBD TBD
Theme 1 horizontal initiative activities
Departments Link to department’s Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Substance Use and Addictions Program (SUAP) Grants and Contributions Funding $113,937,570Footnote 1 $29,732,399Footnote 2 ER 1.1.1 PI 1.1.1 T 1.1.1 TBD
ER 1.1.2 PI 1.1.2 T 1.1.2
Controlled Substances Problematic prescription drug use (PPDU) $16,553,028 $1,976,940 ER 1.1.3 PI 1.1.3 T 1.1.3 March 31, 2021
Indigenous Services Canada Mental Wellness Problematic prescription drug use (PPDU) $14,376,000 $2,900,000 Not applicable
Royal Canadian Mounted Police Federal Policing (FP) Federal Policing Public Engagement (FPPE) $11,110,528 $2,189,330 ER 1.2 PI 1.2.1 T 1.2.1 March 31, 2021
PI 1.2.2 T 1.2.2
PI 1.2.3 T 1.2.3
PI 1.2.4 T 1.2.4
PI 1.2.5 T 1.2.5
Footnote 1

This amount represents the global SUAP CDSS budget. The SUAP does not allocate or track funding by CDSS pillar/theme. SUAP funding will be allocated across the prevention and treatment theme areas.

Return to footnote 1 referrer

Footnote 2

SUAP Planned spending for 2020-21 has increased to $29,732,399 due to the re-profile from 2017-18 and 2018-19 lapses totalling $6,944,885.

Return to footnote 2 referrer

Theme 2 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 Federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 2:
Treatment
$93,711,752 $18,384,040 Health Canada is working with the other federal CDSS partners to update the shared outcome(s) Health Canada is working with the other federal CDSS partners to review and update the performance indicator(s) for this theme TBD TBD
Theme 2 horizontal initiative activities
Departments Link to department’s Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Canadian Institutes of Health Research Research in Priority Areas Research on Drug Treatment Model $6,874,990 $974,998 ER 2.1 PI 2.1 T 2.1 March 31, 2021
Department of Justice Canada Drug Treatment Court Funding Program Drug Treatment Court Funding Program $18,521,552 $3,746,000 ER 2.2.1 PI 2.2.1 T 2.2.1 March 31, 2021
Youth Justice Youth Justice Fund $7,957,625 $1,591,525 ER 2.2.2 PI 2.2.2 T 2.2.2 March 31, 2021
Indigenous Services Canada Mental Wellness Grants and Contributions – Mental Wellness Program $60,357,585 $12,071,517 Not applicable
Theme 3 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 Federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 3:
Harm reduction
$63,415,181 $13,470,181 Reduction in risk-taking behaviour among drug or substances users Number of First Nations people and Inuit per community who received problematic substance use community-based supports  TBD March 31, 2021
Percentage decrease in the number of people who use drugs who report sharing drug use equipment. 10% decrease March 31, 2021
Theme 3 horizontal initiative activities
Departments Link to department’s Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Controlled Substances Strengthening the Canadian Drugs and Substances Strategy $18,415,181 $2,470,181 ER 3.1 PI 3.1 T 3.1 March 31, 2021
Indigenous Services Canada Mental Wellness Grants and Contributions –First Nations and Inuit health programming $15,000,000 $4,000,000 ER 3.2 PI 3.2 T 3.2 March 31, 2021
Public Health Agency of Canada Communicable Diseases and Infections Control Grants and contributions - Transmission of Sexually Transmitted and Blood Borne Infections $30,000,000 $7,000,000 ER 3.3 PI 3.3 T 3.3 March 31, 2021
Theme 4 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 Federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 4:
Enforcement
$273,765,692 $53,352,523 Health Canada is working with the other federal CDSS partners to update the shared outcome(s) Health Canada is working with the other federal CDSS partners to review and update the performance indicator(s) for this theme TBD TBD
Theme 4 horizontal initiative activities
Departments Link to department’s Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Controlled Substances  Controlled Substances Directorate Enforcement Activities $31,221,420 $6,244,284 ER 4.1.1 PI 4.1.1 T 4.1.1 March 31, 2021
Regulatory Operations and Enforcement Branch for Compliance and Enforcement Activities $9,753,510 $1,950,702 ER 4.1.2 PI 4.1.2 T 4.1.2 TBD
Drug Analysis Services $53,825,065 $10,765,013 ER 4.1.3 PI 4.1.3 T 4.1.3 March 31, 2021
ER 4.1.4 PI 4.1.4 T 4.1.4 March 31, 2021
Canada Border Services Agency Risk Assessment Targeting Intelligence Security Screening $10,500,000 $2,100,000 ER 4.2.1 PI 4.2 T 4.2 March 31, 2021
ER 4.2.2
Criminal Investigations $1,000,000 $200,000 ER 4.2.3
Canada Revenue Agency Domestic Compliance Small and Medium Enterprises Directorate $4,209,225 $1,018,613 ER 4.3 PI 4.3 T 4.3 March 31, 2021
Correctional Service Canada Correctional Interventions Case Preparation and Supervision of Provincial Offenders $3,027,280 $747,347 ER 4.4 PI 4.4.1 T 4.4.1 March 31, 2021
PI 4.4.2 T 4.4.2
Community Supervision Case Preparation and Supervision of Provincial Offenders $6,231,200 $1,104,350 PI 4.4.3 T 4.4.3
Financial Transactions and Reports Analysis Centre of Canada Financial Intelligence Program Financial Intelligence Program $0 $0 ER 4.5 PI 4.5 T 4.5 Not applicable
Global Affairs Canada Diplomacy, Advocacy and International Agreements Annual Voluntary Contributions to the United Nations Office on Drugs and Crime (UNODC) and the Inter-American Drug Abuse Control Commission (CICAD) of the American States (OAS) $4,500,000 $900,000 ER 4.6 PI 4.6.1 T 4.6.1 March 31, 2021
PI 4.6.2 T 4.6.2
Parole Board of Canada Conditional Release Decisions Conditional Release Decisions – (Provincial reviews) $5,557,500 $178,000 ER 4.7.1 PI 4.7.1 T 4.7.1 March 31, 2021
Conditional Release Decisions Openness and Accountability Conditional Release Decisions Openness and Accountability (Provincial reviews) $2,137,500 $86,000 ER 4.7.2 PI 4.7.2 T 4.7.2 March 31, 2021
Public Prosecution Service of Canada Drug, National Security and Northern Prosecutions Program Prosecution of serious drug offences under the CDSA to which mandatory minimum penalties are applicable $36,219,785 $7,243,957 ER 4.8.1 PI 4.8.1.1 T 4.8 Not applicable
PI 4.8.1.2
Prosecution and Prosecution-related Services $16,977,150 $3,395,430 ER 4.8.2 PI 4.8.2.1
PI 4.8.2.2
Public Safety Canada Law Enforcement National Coordination of Efforts to Improve Intelligence, Knowledge, Management, Research, Evaluation $2,942,660 $ 530,000 ER 4.9 PI 4.9 T 4.9 March 31, 2021
Public Services and Procurement Canada Specialized Programs and Services Financial Intelligence Program $3,000,000 $600,000 ER 4.10 PI 4.10.1 T 4.10 March 31, 2021
PI 4.10.2
Royal Canadian Mounted Police Federal Policing (FP) Investigations Federal Policing Project-Based Investigations $82,663,397 $16,288,827 ER 4.11 PI 4.11.1 T 4.11 Not applicable
PI 4.11.2
PI 4.11.3
Theme 5 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 Federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 5:
Evidence base
$19,365,379 $4,343,170 Data and research evidence on drugs, and emerging drug trends, are used by members of the federal Health Portfolio and their partners Percentage of targeted stakeholders reporting that they made evidence informed improvements to substance use policies, programs and practice 18% March 31, 2022
Theme 5 horizontal initiative activities
Departments Link to department’s Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Controlled Substances Drug Use Surveillance and Monitoring $8,520,776 $2,249,449 ER 5.1 PI 5.1 T 5.1 March 31, 2022
Canadian Institutes of Health Research Horizontal Health Research Initiative Canadian Research Initiative in Substance Misuse (CRISM) $10,000,000 $2,000,000 ER 5.2 PI 5.2.1 T 5.2.1 March 31, 2022
PI 5.2.2 T 5.2.2
Public Health Agency of Canada Emergency Preparedness and Response Chronic Disease and Injury Surveillance $844,603 $93,721 ER 5.3 PI 5.3 T 5.3 March 31, 2021
Total spending, all themes
Theme Total federal funding allocated since last renewal
(dollars)
2020–21 total federal planned spending
(dollars)
Theme 1 $155,977,126 $36,798,669
Theme 2 $93,711,752 $18,384,040
Theme 3 $63,415,181 $13,470,181
Theme 4 $273,765,692 $53,352,523
Theme 5 $19,365,379 $4,343,170
Total, all themesFootnote 1 $606,235,130 $126,348,583
Footnote 1

Funding does not include internal services and lead role.

Return to footnote 1 referrer

Theme 1: Prevention

Expected results

Health Canada

Royal Canadian Mounted Police

Performance indicators

Health Canada

Royal Canadian Mounted Police

Targets

Health Canada

Royal Canadian Mounted Police

Theme 2:  Treatment

Expected results

Canadian Institutes of Health Research

Department of Justice Canada

Performance indicators

Canadian Institutes of Health Research

Department of Justice Canada

Targets

Canadian Institutes of Health Research

Department of Justice Canada

Theme 3:  Harm reduction

Expected results

Health Canada

Indigenous Services Canada

Public Health Agency of Canada

Performance indicators

Health Canada

Indigenous Services Canada

Public Health Agency of Canada

Targets

Health Canada

Indigenous Services Canada

Public Health Agency of Canada

Theme 4:  Enforcement

Expected results

Health Canada

Canada Border Services Agency

Canada Revenue Agency

Correctional Services Canada

Financial Transactions and Reports Analysis Centre of Canada.

Global Affairs Canada

Parole Board of Canada

Public Prosecution Service of Canada

Public Safety Canada

Public Services and Procurement Canada

Royal Canadian Mounted Police

Performance indicators

Health Canada

Canada Border Services Agency

Canada Revenue Agency

Correctional Services Canada

Financial Transactions and Reports Analysis Centre of Canada

Global Affairs Canada

Parole Board of Canada

Public Prosecution Service of Canada

Public Safety Canada

Public Services and Procurement Canada

Royal Canadian Mounted Police

Targets

Health Canada

Canada Border Services Agency

Canada Revenue Agency

Correctional Services Canada

Financial Transactions and Reports Analysis Centre of Canada

Global Affairs Canada

Parole Board of Canada

Public Prosecution Service of Canada

Public Safety Canada

Public Services and Procurement Canada

Royal Canadian Mounted Police

Theme 5:  Evidence base

Expected results

Health Canada

Canadian Institutes of Health Research

Public Health Agency of Canada

Performance indicators

Health Canada

Canadian Institutes of Health Research

Public Health Agency of Canada

Targets

Health Canada

Canadian Institutes of Health Research

Public Health Agency of Canada

Chemicals Management Plan

General information

Name of horizontal initiative
Chemicals Management Plan
Lead department
Health Canada
Environment and Climate Change Canada
Federal partner organization(s)
Public Health Agency of Canada
Start date
2007-08
End date
2020-21
Description

Originally launched in 2006, the Chemicals Management Plan (CMP) enables the Government of Canada to protect human health and the environment by addressing substances of concern in Canada.

Jointly managed by Health Canada and Environment and Climate Change Canada, the CMP brings all existing federal chemical programs together under a single strategy. This integrated approach allows the Government of Canada to address various routes of exposure to chronic and acute hazardous substances. It also enables use of the most appropriate management tools among a full suite of federal laws, which include the Canadian Environmental Protection Act, 1999 (CEPA), the Canada Consumer Product Safety Act (CCPSA), the Food and Drugs Act (F&DA), the Pest Control Products Act (PCPA), and the Fisheries Act.

The third phase (CMP3) includes both substance groupings and single substance assessments. Similar to CMP2, groupings are created where possible to gain efficiencies in the assessment process. Where groupings are not possible, single substance assessments are conducted.

Integration across government programs remains critical since many substances are found in consumer, cosmetic, health, drug and other products. In addition to releases from products, substances may be released at various points along other areas of their life cycle, such as during the manufacturing and disposal.

The same core functions that have been part of phases one and two continue in phase three of the CMP: risk assessment; risk management; compliance promotion and enforcement; research; monitoring and surveillance; stakeholder engagement and risk communications; and, policy and program management. Information gathering is a key activity undertaken to support these core functions.

For more information, see the Government of Canada's Chemical Substances Portal.

Governance structure

In the overall delivery of the CMP, Health Canada and Environment and Climate Change Canada have a shared responsibility in attaining objectives and results. In meeting their obligations pursuant to the CMP, the Departments fulfill their responsibilities through established internal departmental governance structures, as well as a joint CMP governance structure to address shared responsibilities. Efforts are also made to harmonize vertical and horizontal performance reporting indicators (e.g., CMP Performance Measurement Strategy, the CMP contribution to the Federal Sustainable Development Strategy, etc.) for CMP.

The CMP has a horizontal governance framework which ensures integration, co-ordination, joint decision making and clear accountabilities. Under the CMP Integrated Horizontal Governance Framework, the joint CMP Assistant Deputy Ministers Committee (CMP ADM Committee) reports to both the Health Canada and Environment and Climate Change Canada Deputy Ministers.

The CMP ADM Committee is supported by a Director General (DG) Committee. The CMP DGs Committee consists of DGs from all partner programs within Health Canada and Environment and Climate Change Canada, and provides strategic direction, oversight and a challenge function for the CMP's overall implementation. The CMP DGs also play a lead role in directing, monitoring and providing a challenge function for the core elements of the CMP, namely the delivery of the chemicals agenda under CEPA.

This DG level committee is supported by the CMP Steering Committee, which is a Director level committee intended to provide oversight on CMP issues related to the CEPA chemicals agenda.

Total federal funding allocated from start to end date (dollars)
$1,308,179,400
Total federal planned spending to date (dollars)
$1,110,864,820
Total federal actual spending to date (dollars)
$1,069,428,868 (includes Phases I, II and Phase III)
Date of last renewal of initiative
October 2014
Total federal funding allocated at last renewal and source of funding (dollars)
Phase three, $493,286,450; Source of funding: Budget 2015
Additional federal funding received after last renewal (dollars)
Not applicable
Total planned spending since last renewal
$295,971,870
Total actual spending since last renewal
$293,343,720
Fiscal year of planned completion of next evaluation
The last evaluation was done in 2019-20. The next evaluation is not yet planned.

Planning highlights

In 2020-21, the program will continue to assess and manage the potential health and ecological risks from the remaining priority existing substances from CMP1 and CMP2 and continue science based assessment and risk management activities, as needed, on the potential health and ecological risks associated with approximately 1,550 existing substances included in CMP3. With CMP program funding ending in March 2021, the program has also begun exploring options for program renewal and elements to be addressed in the future.

A key activity undertaken to support the core functions of the CMP is information gathering. This involves a range of voluntary and mandatory activities, ensuring the engagement of stakeholders. Having up-to-date information and understanding trends in the Canadian marketplace are necessary to inform risk assessment and risk management activities and support sound decision making by the Government.

Draft Screening Assessment Reports covering approximately 317 substances are planned to be published in 2020-21, as are Final Screening Assessments Reports for approximately 324 substances.

Proposed and Final Risk Management Instruments will be developed and published in Part I or Part II of the Canada Gazette, as required. The program will also continue to use the new substances program to identify and manage, as appropriate, the human health and environmental risks of new substances before import to, or manufacture in, Canada.

In 2020-21, the program will continue to conduct risk assessments and develop and implement risk management measures to address identified risks posed by harmful chemicals in foods and food packaging materials, consumer products, cosmetics and drinking water. Work will also continue on substances/products regulated under the F&DA and on the re-evaluation of the remaining older chemicals (registered prior to 1995) and the cyclical re-evaluation of pesticides registered after 1995.

The Public Health Agency of Canada (PHAC) will continue its risk-based inspection program to identify and address human health risks associated with water, food and sanitation on passenger conveyances such as aircraft, trains, cruise ships and ferries, focusing efforts on areas of greatest risk to public health.

The program will conduct targeted monitoring and surveillance activities to address existing and emerging chemicals of concern, and to inform risk assessment needs and risk management activities. Research will continue in order to address outstanding questions and knowledge gaps related to the effects and exposure of chemical substances to humans and the environment to inform risk management, risk assessment and international activities.

The program will develop implementation strategies and will continue to deliver activities to raise regulatees' awareness and understanding of, and promote their compliance with regulatory requirements for certain assessed CMP substances.

The program will continue to increase proactive communications to the public to raise awareness of the risks and safe use of substances, including greater use of partnerships to expand the reach of messaging, with a focus on vulnerable populations. Efforts to advance the sound management of chemicals through participation in a range of international activities that support domestic efforts will continue in 2020-21 as well.

Contact information

Health Canada

Suzanne Leppinen
Director
Healthy Environments and Consumer Safety Branch
Suzanne.Leppinen@canada.ca
613-941-8071

Environment and Climate Change Canada

Andrea Raper
A/Executive Director, Program Development and Engagement
Science and Technology Branch
Andrea.Raper@canada.ca
819-938-4569

Christina Paradiso
Executive Director, Chemicals Management Division
Environmental Protection Branch
Christina.Paradiso@canada.ca
819-938-4590

Planning information

Horizontal initiative overview
Name of horizontal initiative Total federal funding allocated since last renewalTable 31 Footnote 1
(dollars)
2020–21 planned spending
(dollars)
Horizontal initiative shared outcome(s) Performance indicator(s) Target(s) Date to achieve target
Chemicals Management Plan $493,286,450 $98,657,290 Reduced threats to health and the environment from harmful substances. Long-term risk of a selected group of harmful substances where risk management actions have been put in place. Downward trend - This is a long term outcome with no specific targets. March 31, 2028
Risk management measures reduce the potential for exposure to harmful substances. Exposure or release levels of a select group of harmful substances where risk management measures have been put in place. (Substance-based Performance Measurement). Downward trend - This is a long term outcome with no specific targets. March 31, 2022
Canadians use the information (that meets their needs on the risks and safe use of substances of concern) to avoid or minimize risks posed by substances of concern. (i) Percentage of Canadians taking appropriate actions to address risks (targeted stakeholders/intermediaries). (i) 80% (i) March 31, 2022
(ii) Percentage of Canadians taking appropriate actions to address risks (general public). (ii) TBD (ii) TBD
Table 31 Footnote 1

This amount includes any additional funding received after the last renewal. Where the initiative is new (with no renewal), insert the initial total allocation approved.

Table 31 Return to footnote 1 referrer

Theme 1 horizontal initiative activities
Departments Link to department’s Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewalTable 32 Footnote 1
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Health Impacts of Chemicals Health Products:
Risk Assessment
$6,136,645 $1,227,329 ER 1.1 PI 1.1.3 T 1.1.3 March 31, 2021
Food Safety and Nutrition:
Risk Assessment
$6,186,965 $1,237,393 ER 1.1 PI 1.1.1 T 1.1.1 March 31, 2021
PI 1.1.2 T 1.1.2 March 31, 2021
Env. Risks to Health:
Risk Assessment
$51,766,940 $10,353,388 ER 1.1 PI 1.1.3 T 1.1.3 March 31, 2021
PI 1.1.4 T 1.1.4 March 31, 2021
Consumer Product and Workplace Hazardous Materials:
Risk Assessment
$12,098,165 $2,419,633 ER 1.1 PI 1.1.3 T 1.1.3 March 31, 2021
Health Products:
Risk Management, Compliance Promotion and Enforcement
$4,251,945 $850,389 ER 1.2 PI 1.2.1 T 1.2.1 March 31, 2021
Food Safety and Nutrition:
Risk Management, Compliance Promotion and Enforcement
$5,901,575 $1,180,315 ER 1.2 PI 1.2.1 T 1.2.1 March 31.2021
Env. Risks to Health:
Risk Management, Compliance Promotion and Enforcement
$35,431,185 $7,086,237 ER 1.2 PI 1.2.1 T 1.2.1 March 31, 2021
ER 1.3 PI 1.3 T 1.3 March 31, 2021
Consumer Product and Workplace Hazardous Materials:
Risk Management, Compliance Promotion and Enforcement
$12,748,975 $2,549,795 ER 1.2 PI 1.2.1 T 1.2.1 March 31, 2021
Health Products:
Research
- - Not applicable Not applicable Not applicable Not applicable
Food Safety and Nutrition:
Research
$3,476,195 $695,239 ER 1.4 PI 1.4 T 1.4 March 31, 2021
Env. Risks to Health:
Research
$49,822,575 $9,964,515 ER 1.4 PI 1.4 T 1.4 March 31. 2021
Health Products:
Monitoring and Surveillance
- - Not applicable Not applicable Not applicable Not applicable
Food Safety and Nutrition:
Monitoring and Surveillance
$4,757,430 $951,486 ER 1.5 PI 1.5 T 1.5 March 31, 2021
Env. Risks to Health:
Monitoring and Surveillance
$49,298,520 $9,859,704 ER 1.5 PI 1.5 T 1.5 March 31, 2021
Food Safety and Nutrition:
Stakeholder Engagement and Risk Communications
$848,425 $169,685 ER 1.6 PI 1.6 T 1.6 March 31, 2021
Env. Risks to Health:
Stakeholder Engagement and Risk Communications
$14,076,085 $2,815,217 ER 1.6 PI 1.6 T 1.6 March 31, 2021
Env. Risks to Health:
Policy and Program Management
$11,041,590 $2,208,318 Not applicable Not applicable Not applicable Not applicable
Pesticides Pesticides:
Risk Assessment
$22,817,180 $4,563,436 ER 1.1 PI 1.1.5 T 1.1.5 March 31, 2021
Pesticides:
Risk Management, Compliance Promotion and Enforcement
$4,232,080 $846,416 ER 1.2 PI 1.2.2 T 1.2.2 March 31, 2021
Pesticides:
Research
- - Not applicable Not applicable Not applicable Not applicable
Internal Services – Health Canada $34,979,720 $6,995,944 - - - -
Public Health Agency of Canada Border Health Security Border Health:
Risk Management, Compliance Promotion and Enforcement
$15,914,255 $3,182,851 ER 2.1 PI 2.1 T 2.1 March 31, 2021
Environment and Climate Change Canada Substances and Waste Management Substances and Waste Management:
Risk Assessment
$19,367,335 $3,873,467 ER 3.1 PI 3.1.1 T 3.1.1 March 31, 2021
PI 3.1.2 T 3.1.2
Substances and Waste Management:
Risk Management
$67,624,765 $13,524,953 ER 3.2 PI 3.2 T 3.2 March 31, 2021
Substances and Waste Management:
Research
$9,420,790 $1,884,158 ER 3.3 PI 3.3 T 3.3 March 31, 2021
Substances and Waste Management:
Monitoring and Surveillance
$24,399,675 $4,879,935 ER 3.4 PI 3.4 T 3.4 March 31, 2021
Compliance Promotion and Enforcement – Pollution:
Compliance Promotion
$4,272,045 $854,409 ER 3.5 PI 3.5 T 3.5 March 31, 2021
Compliance Promotion and Enforcement – Pollution:
Enforcement
$11,075,675 $2,215,135 ER 3.6 PI 3.6 T 3.6 March 31, 2021
Internal Services – Environment and Climate Change Canada $11,339,715 $2,267,943 - - - -
Total for all federal organizations $493,286,450 $98,657,290 - - - -
Table 32 Footnote 1

This amount includes any additional funding received after the last renewal. Where the initiative is new (with no renewal), insert the initial total allocation approved.

Table 32 Return to footnote 1 referrer

Expected Results:

Health Canada:

Public Health Agency of Canada

Environment and Climate Change Canada

Performance Indicators:

Health Canada

Public Health Agency of Canada

Environment and Climate Change Canada

Targets:

Health Canada

Public Health Agency of Canada

Environment and Climate Change Canada

New Federal Framework for the Legalization and Regulation of Cannabis

General information

Name of horizontal initiative

Implementing a New Federal Framework for the Legalization and Strict Regulation of Cannabis

Lead department

Health Canada

Federal partner organization(s)

Note: Other government departments (e.g., the Department of Justice) are supporting the federal cannabis framework. However, they are not captured in this Horizontal Initiative table, as they have not received targeted funding to support this initiative, "Implementing a New Federal Framework for the Legalization and Strict Regulation of Cannabis".

Start date

April 1, 2017

End date

March 31, 2022

Description

The objective of this horizontal initiative is to implement and administer the federal framework to legalize and strictly regulate cannabis. The Cannabis Act received Royal Assent on June 21, 2018, and came into force on October 17, 2018. The initiative is designed to follow through on the Government's key objectives of protecting public health, safety, and security. More specifically, the initiative aims to prevent young persons from accessing cannabis, to protect public health and public safety by establishing strict product safety and product quality requirements and to deter criminal activity by imposing serious criminal penalties for those operating outside the legal framework.

Federal partner organizations implement ongoing delivery of the regulatory framework including licensing; compliance and enforcement; surveillance; research; national public education and awareness activities; and framework support.
The initiative also supports law enforcement capacity to collect and assess intelligence on the evolution of organized crime involvement in the illicit cannabis market and other related criminal markets.

Activities are organized by five high-level themes:

  1. Establish, implement and enforce the new legislative framework;
  2. Provide Canadians with information needed to make informed decisions and minimize health and safety harms;
  3. Build law enforcement knowledge and engage partners and stakeholders on public safety;
  4. Provide criminal intelligence, enforcement and related training activities; and
  5. Prevent and interdict prohibited cross-border movement of cannabis while maintaining the flow of legitimate travelers and goods.

Governance structure

The Government of Canada continues to support a robust governance structure to facilitate whole-of-government coordination in implementing and administering the federal framework to legalize and strictly regulate cannabis. At the federal level, this governance structure includes: an Assistant Deputy Minister's Committee that serves as a forum for government-wide coordination of policy and implementation activities; a Directors-General Committee that is responsible for coordinating policy, regulatory development, and implementation activities across federal departments and agencies; and, a Federal Partners Cannabis Data Working Group to promote horizontal collaboration and support evidence-based policy and program development.

Health Canada's Controlled Substances and Cannabis Branch assumes a central coordinating role in tracking key project milestones and in reporting to federal Ministers.

The Government is committed to ongoing collaboration and consultation with provincial and territorial partners. In May 2016, the Federal/Provincial/Territorial (F/P/T) Senior Officials Working Group on Cannabis Legalization and Regulation was established, to enable F/P/T governments to exchange information on important issues about the legalization and regulation of cannabis throughout the consultation, design and implementation of the legislation, regulations, and non-regulatory activities. Supporting F/P/T working groups and committees also facilitate ongoing engagement in key priority areas, including public education and awareness, data development and information sharing, national inventory tracking and implementation. In addition, existing F/P/T bodies are also considering the implications of cannabis legalization and regulation, including F/P/T Deputy Ministers Responsible for Justice and Public Safety, and F/P/T Ministers Responsible for Finance.

Total federal funding allocated from start to end date (dollars)

$546,807,456

Total federal planned spending to date (dollars)

$168,865,207

Total federal actual spending to date (dollars)

$142,659,398

Date of last renewal of initiative

Not applicable

Total federal funding allocated at last renewal and source of funding (dollars)

Not applicable

Additional federal funding received after last renewal (dollars)

Not applicable

Total planned spending since last renewal

Not applicable

Total actual spending since last renewal

Not applicable

Fiscal year of planned completion of next evaluation

2022-23

Planning highlights

The federal government will continue to support the effective implementation of the new cannabis framework in 2020-21, working with provinces, territories, Indigenous governments, municipalities, non-governmental organizations, and communities to meet its objectives. For 2020-21, the federal government will continue to oversee the regulation of licence holders who cultivate and process cannabis as well as standards for products, packaging and labelling, and prohibitions on promotion, that are designed to protect the health and safety of Canadians. Provinces and territories are responsible for determining how cannabis is distributed and sold in their jurisdictions.

More specifically, participating federal departments and agencies have identified the following key priorities for 2020-21.

Health Canada

In 2020-21, Health Canada will:

Canada Border Services Agency

In 2020-21, CBSA will continue to advance initiatives that support the identification and interception of high-risk people, goods and conveyances that pose a threat to the security of Canadians with respect to the illegitimate cross-border movement of cannabis. Planning highlights for 2020-21 include:

Public Health Agency of Canada

In 2020-21, PHAC will continue to support the role of Canada's Chief Public Health Officer by undertaking the following:

Public Safety Canada

In 2020-21, PS will:

Royal Canadian Mounted Police

In 2020-21, the RCMP will work collaboratively to develop appropriate responses, including targeted awareness products, through ongoing interactions with stakeholders. The RCMP will identify trends related to organized crime infiltration and money-making schemes in relation to both the legitimate and the illegal markets. Through in-person engagement and the use of technology, the RCMP will continue to focus on increasing awareness and education of cannabis legalization, with an emphasis on possession, production, and distribution of cannabis for Indigenous and youth populations by undertaking the following select initiatives:

The RCMP will play a key coordinating role in stakeholder engagement, establishing networks and in the development and distribution of national awareness products to ensure consistency and support for stakeholder outreach. In 2020-21, Federal Policing Prevention and Engagement work will focus on:

In 2020-21, the RCMP will continue its efforts to support training and capacity development by engaging in the following activities:

The RCMP will continue to work with partners on various cannabis policy related initiatives, such as the approach to law enforcement in Indigenous communities, online illegal dispensaries, and regulations related to cannabis edibles, extracts and topicals. Furthermore, in 2020-21, the RCMP will leverage existing forums such as the Canadian Association Chiefs of Police to discuss and advance current or emerging policy initiatives.

The RCMP will continue to develop criminal intelligence products to identify, target, and disrupt criminal involvement in the Canadian cannabis market, and share intelligence with law enforcement agencies, domestic government partners, and international law enforcement partners. In 2020-21, the RCMP will continue to:

The RCMP will continue to support the Minister of Health's decisions on security clearances required as part of the licensing regime for cannabis cultivators and processors, which includes identifying criminality or associations to criminal organizations and verifying this information with the law enforcement organizations of jurisdiction.

Contact information

Health Canada

John Clare
A/Director General
Controlled Substances and Cannabis Branch
John.Clare@canada.ca
613-941-8371

Horizontal initiative framework: departmental funding by theme (dollars)

Horizontal initiative: Implementing a New Federal Framework for the Legalization and Strict Regulation of Cannabis

Shared outcomes:

Name of theme Theme Area 1: Establish, implement and enforce the new horizontal initiative Theme Area 2: Provide Canadians with information needed to make informed decisions and minimize health and safety harms Theme Area 3: Build law enforcement knowledge and engage partners and stakeholders on public safety Theme Area 4: Provide criminal intelligence, enforcement and related training activities Theme Area 5: Prevent and interdict prohibited cross-border movement of cannabis while maintaining the flow of legitimate travellers and goods Internal Services

Theme outcome(s)

  • A federally licensed and regulated (non-medical) industry is established [HC];
  • The federally licensed industry understands the legislation and regulatory requirements [HC];
  • The federally licensed industry is found to be compliant with regulatory requirements [HC]; and,
  • Law Enforcement Records Checks are conducted in support of Health Canada's security clearance decisions [RCMP].
  • Canadian youth understand the potential health and safety risks associated with cannabis use [HC];
  • Canadians use information to make informed decisions about the potential health and safety risks associated with the use of cannabis [HC];
  • Health care and social service professionals and public health officials have access to high-quality public health information [PHAC];
  • Health care and social service professionals and public health officials use information, knowledge and data products related to the public health impacts of cannabis and interventions to address them [PHAC];
  • Canadians are aware of the legal implications associated with cannabis use, and understand the laws associated with the new legislation [PS]; and,
  • Canadians use information provided by the program to make informed, lawful decisions [PS].
  • Law enforcement is well-informed to apply the new legislation [PS];
  • Evidence-based decision-making on organized crime and policing issues [PS];
  • Research projects related to cannabis and performance measurement implemented [PS];
  • Policy development and decision-making is informed by evidence and performance measurement [PS];
  • RCMP prevention and engagement activities support enhanced understanding among targeted partners and stakeholders, including youth and Indigenous communities [RCMP]; and,
  • Enhanced capacity of target populations, including partners and stakeholders, youth and Indigenous communities, to respond to the new cannabis regime [RCMP].
  • Information and intelligence products/advice related to illicit substances (including cannabis) are shared with Canadian law enforcement agencies and available to be used to target organized crime [RCMP];
  • Canadian law enforcement agencies have intelligence information to nationally coordinate activities to target organized crime groups involved in the Canadian cannabis market [RCMP];
  • RCMP staff have access to required training in regards to enforcement of the new cannabis regime [RCMP]; and,
  • RCMP employees have an increased ability to enforce the new cannabis regime [RCMP].
  • Travellers understand the requirements to declare cannabis and cannabis-related products when entering Canada [CBSA];
  • Travellers are provided a clear opportunity to declare cannabis in their possession at all primary inspection sites [CBSA];
  • CBSA has enhanced capacity to promote compliance and to enforce import-related laws [CBSA];
  • Prohibited cross border movement of cannabis is detected [CBSA];
  • Border-related regulations, accompanying policies and procedures, agreements, studies, and monitoring framework are developed and implemented [CBSA]; and,
  • Travellers and the import/export community have access to recourse mechanisms to challenge certain CBSA actions and decisions in a timely manner [CBSA].

Not applicable

Health Canada $370,394,429 $16,121,003 Not applicable Not applicable Not applicable $44,485,622
Canada Border Services Agency Not applicable Not applicable Not applicable Not applicable $34,600,853 $5,095,567
Public Health Agency of Canada Not applicable $2,586,174 Not applicable Not applicable Not applicable $206,951
Public Safety Canada Not applicable $1,173,345 $3,810,640 Not applicable Not applicable $500,353
Royal Canadian Mounted Police $17,972,092 Not applicable $14,003,082 $26,798,704 Not applicable $9,058,641

Planning information

Horizontal initiative overview
Name of horizontal initiative Total federal funding allocated since last renewal
(dollars)
2020–21 planned spending
(dollars)
Horizontal initiative shared outcome(s) Performance indicator(s) Target(s) Date to achieve target
Implementing a New Federal Framework for the Legalization and Strict Regulation of Cannabis $546,807,456 SO 1. Cannabis is kept out of the hands of Canadian children and youth [HC] Percentage of Canadians (aged 15-17 and 18-24) who used cannabis in the last 12 months [HC] TBD by August 31, 2020 TBD by August 31, 2020
SO 2. Criminal involvement in the illicit cannabis market is reduced [CBSA and RCMP] Qualitative assessment on trends related to criminal involvement in the illicit cannabis market [RCMP] TBD by March 31, 2020 TBD by March 31, 2020
Number of cannabis import interdictions at the border [CBSA] TBD by April 30, 2020 TBD by April 30, 2020
Table 34 Footnote 1

This amount includes internal services of $16,069,525.

Table 34 Return to footnote 1 referrer

Table 34 Footnote 2

This amount includes internal services of $2,110,978.

Table 34 Return to footnote 2 referrer

Table 34 Footnote 3

This amount includes internal services of $1,314,883.

Table 34 Return to footnote 3 referrer

Table 34 Footnote 4

The total amount includes Internal Services of $82,158.

Table 34 Return to footnote 4 referrer

Table 34 Footnote 5

This amount includes internal services of $45,988.

Table 34 Return to footnote 5 referrer

Theme 1 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 1: Establish, implement and enforce the new horizontal initiative HC:
$370,394,429
RCMP:
$17,972,092
HC:
$89,818,843
RCMP:
$4,867,525
A federally licensed and regulated (non-medical) industry is established [HC] Number of licence applications (decisions) per year [HC] 1,050 March 31, 2021
Percentage of licence applications reviewed within internal service standards [HC] 75% March 31, 2021
The federally licensed industry understands the legislation and regulatory requirements [HC] % of federal licence holders who indicate they have access to information to help them understand the regulatory requirementsTable 35 Footnote 1 [HC] 80% March 31, 2021
The federally licensed industry is found to be compliant with regulatory requirements [HC] Percentage of federally licensed industry that is found to be compliant with regulatory requirements [HC] 95% March 31, 2022
Law Enforcement Records Checks (LERCs) are conducted in support of HC's security clearance decisions [RCMP] Percentage of LERCs completed within negotiated service standards [RCMP] 75%Table 35 Footnote 2 March 31, 2021
Table 35 Footnote 1

This indicator has been modified to better assess the impact of program activities on licence holders.

Table 35 Return to footnote 1 referrer

Table 35 Footnote 2

The RCMP has applied an internal service level objective of 75% of all files with no adverse information completed within 15 business days.

Table 35 Return to footnote 2 referrer

Theme 1 horizontal initiative activities
Departments Link to department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Cannabis Program License federal producers and other legal market participants; provide client registration and other client services $ 211,618,075 49,991,081 ER 1.1.1 PI 1.1.1.1 T 1.1.1.1 March 31, 2021
PI 1.1.1.2 T 1.1.1.2 March 31, 2021
Compliance and enforcement: Design and promote compliance and enforcement; robust inspection program, involving pre- and post-licence inspections $ 158,776,354 $39,827,762 ER 1.1.2 PI 1.1.2 T 1.1.2 March 31, 2021
ER 1.1.3 PI 1.1.3 T 1.1.3 March 31, 2022
Royal Canadian Mounted Police RCMP Departmental Security Build capacity to provide security screening reports (i.e., LERCs) to Health Canada to complete applications for the production of cannabis for non-medical purposes $17,972,092 $4,867,525 ER 1.2 PI 1.2 T 1.2 March 31, 2021
Theme 2 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 Federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 2: Provide Canadians with information needed to make informed decisions and minimize health and safety harms
  • HC:
    $16,121,003
  • PHAC:
    $2,586,174
  • PS:
    $1,173,345
  • HC:
    $919,860
  • PHAC:
    $577,484
  • PS:
    $314,669
Canadian youth understand the potential health and safety risks associated with cannabis use [HC] Percentage of youth (grades 7-12) who perceive that there is “no risk” in smoking cannabis on a regular basis [HC]Table 37 Footnote 1 TBD by August 31, 2020 TBD by August 31, 2020
Canadians use information to make informed decisions about the potential health and safety risks associated with the use of cannabis [HC] Percentage of parents who discuss cannabis with their youthTable 37 Footnote 2 [HC] TBD by December 31, 2020 TBD by December 31, 2020
Health care and social service professionals and public health officials have access to high-quality public health information [PHAC] Number of health care and social service professionals and public health officials accessing high-quality public health information and data products developed [PHAC] TBD by March 31, 2020Table 37 Footnote 3 March 31, 2021
Health care and social service professionals and public health officials use information, knowledge and data products related to the public health impacts of cannabis and interventions to address them [PHAC] Percentage of Chief Public Health Officer’s Health Professionals Forum member organizations using information, knowledge and data products to make informed decisions [PHAC]Table 37 Footnote 4 75% March 31, 2021
Canadians are aware of the legal implications associated with cannabis use, and understand the laws associated with the new legislation [PS] Percentage of Canadians (aged 15-24) who indicate that they are aware of the new legislation, and the consequences related to making certain decisions involving cannabis [PS] TBD by March 31, 2020 March 31, 2022
Canadians use information provided by the program to make informed, lawful decisions [PS] Percentage of Canadians (aged 15-24) who have indicated that they have made informed, lawful decisions around cannabis that protected themselves, and the safety of others [PS] TBD by March 31, 2020 March 31, 2022
Table 37 Footnote 1

The wording of this indicator was slightly modified to align with the survey question.

Table 37 Return to footnote 1 referrer

Table 37 Footnote 2

The target population in this indicator was modified to use consistent term when referring to youth.

Table 37 Return to footnote 2 referrer

Table 37 Footnote 3

A target will be established once two data points are collected.

Table 37 Return to footnote 3 referrer

Table 37 Footnote 4

Minor changes to the wording were made to clarify which organizations are expected to use the information, data and knowledge products.

Table 37 Return to footnote 4 referrer

Theme 2 horizontal initiative activities
Departments Link to department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Health Canada Cannabis Program Public education and outreach: Provide Canadians with information about health and safety risks associated cannabis use $16,121,003 $919,860 ER 2.1.1 PI 2.1.1 T 2.1.1 TBD by August 31, 2020
ER 2.1.2 PI 2.1.2 T 2.1.2 TBD by December 31, 2020
Public Health Agency of Canada Evidence for Health Promotion and Chronic Disease and Injury Prevention Program Develop public health advice to support the role of Canada's Chief Public Health Officer (CPHO) through knowledge translation and horizontal analysis $2,586,174 $577,484 ER 2.2.1 PI 2.2.1 T 2.2.1 March 31, 2021
ER 2.2.2 PI 2.2.2 T 2.2.2 March 31, 2021
Public Safety Crime Prevention Public education and awareness $1,173,345 $314,669 ER 2.3.1 PI 2.3.1 T 2.3.1 March 31, 2022
ER 2.3.2 PI 2.3.2 T 2.3.2 March 31, 2022
Theme 3 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 3: Build law enforcement knowledge and engage partners and stakeholders on public safety PS:
$3,810,640
RCMP:
$14,003,082
PS:
$600,547
RCMP:
$3,259,091
Law enforcement is well-informed to apply the new legislation [PS] Percentage of law enforcement knowledgeable about the changes to the new regime, and able to use the legislative framework as a result of the training materials [PS] 33% of frontline police officers access materials 75% of officers with access to materials find the materials helpful March 31, 2021
Evidence-based decision-making on organized crime and policing issues [PS] Percentage of stakeholders who indicate that the materials informed decision making [PS] 75% March 31, 2021
Number of working meetings and consultations with stakeholders held [PS] 15 March 31, 2021
Number of new initiatives considered for implementation [PS] 2 March 31, 2021
Research projects related to cannabis and performance measurement implemented [PS] Percentage of research projects related to performance measurement completed and disseminated [PS] 100% March 31, 2021
Policy development and decision-making is informed by evidence and performance measurement [PS] Percentage of stakeholders indicating that policy development and decision making was based on performance measurement results and lessons learned [PS] 50% March 31, 2021
RCMP prevention and engagement activities support enhanced understanding among targeted partners and stakeholders, including youth and Indigenous communities [RCMP] Percentage of targeted federal partners and stakeholders who strongly agree or agree with the statement “RCMP Federal Policing contributes to increased understanding specific to the new cannabis regime, organized crime, and the illicit cannabis market” [RCMP] 45% March 31, 2021
Number of information inquiries responded to by the Centre for Youth Crime Prevention [RCMP] 150 March 31, 2021
Enhanced capacity of target populations, including partners and stakeholders, youth and Indigenous communities, to respond to the new cannabis regime [RCMP] Percentage of targeted partners/stakeholders who strongly agree or agree with the statement “RCMP Federal Policing contributes to an increased skills/ability to respond to the new cannabis regime” [RCMP] 30% March 31, 2021
Percentage of youth resource officers who positively assessed the impact of training [RCMP] 80% March 31, 2021
Theme 3 horizontal initiative activities
Departments Link to department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Public Safety Serious and Organized Crime Training for law enforcement $3,810,640 $600,547 ER 3.1.1 PI 3.1.1 T 3.1.1 March 31, 2021
ER 3.1.2 PI 3.1.2.1 T 3.1.2.1 March 31, 2021
PI 3.1.2.2 T 3.1.2.2 March 31, 2021
PI 3.1.2.3 T 3.1.2.3 March 31, 2021
Develop policies to inform operational law enforcement efforts See first amount for Serious and Organized Crime See first amount for Serious and Organized Crime ER 3.1.3 PI 3.1.3 T 3.1.3 March 31, 2021
ER 3.1.4 PI 3.1.4 T 3.1.4 March 31, 2021
Royal Canadian Mounted Police Sub-Sub-Program 1.1.2.5 Public Engagement Enhance RCMP's capacity to develop and deliver prevention and outreach activities on the new cannabis regime from a law enforcement perspective. $5,507,991 $1,580,590 ER 3.2.1 PI 3.2.1.1 T 3.2.1.1 March 31, 2021
PI 3.2.1.2 T 3.2.1.2 March 31, 2021
Sub-Sub-Program 1.1.3.5 Operational Readiness and Response $8,495,091 $1,678,501 ER 3.2.2 PI 3.2.2.1 T 3.2.2.1 March 31, 2021
PI 3.2.2.2 T 3.2.2.2 March 31, 2021
Theme 4 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 4: Provide criminal intelligence, enforcement and related training activities RCMP:
$26,798,704
RCMP:
$4,968,523
Information and intelligence products related to illicit substances (including cannabis) are shared with Canadian law enforcement agencies and available to be used to target organized crime [RCMP] Percentage or number of RCMP information / intelligence products / advice that indicate organized crime groups' activities in the Canadian cannabis market shared with RCMP senior management, divisions, domestic partners (including Canadian law enforcement) or international partners [RCMP] 10 March 31, 2022
Canadian law enforcement agencies have intelligence information to nationally coordinate activities to target organized crime groups involved in the Canadian cannabis market [RCMP] Number of organized crime groups involved in the illicit cannabis market for which there are intelligence gaps is reduced which will result in efficient and accurate targeting by the law enforcement community [RCMP] TBD by December 31, 2022Table 41 Footnote 1 TBD by December 31, 2022
Number or percentage of information and intelligence products that are used to guide enforcement against organized crime groups in the Canadian cannabis market [RCMP] 3 March 31, 2022
RCMP staff have access to required training in regards to enforcement of the new cannabis regime [RCMP] Percentage of target audience who have received the appropriate cannabis related training [RCMP] Federal Policing (FP) training: 100% FP training:
March 31, 2021
Learning and Development: 80% Learning and Development:
October 31, 2021
RCMP employees have an increased ability to enforce the new cannabis regime [RCMP] Percentage of training participants who reported an increased level of knowledge and ability to enforce the new cannabis regime [RCMP] FP training: 90% FP training:
March 31, 2021
Learning and Development: 100% Learning and Development:
October 31, 2021
Table 41 Footnote 1

A target and target date cannot be established at this time as the information available on organized crime groups in relation to cannabis is insufficient due to the reallocation of enforcement resources to other criminal threats. A target and a target date will be established by December 31, 2022, once a new data collection process is implemented.

Table 41 Return to footnote 1 referrer

Theme 5 details
Name of theme Total federal theme funding allocated since last renewal
(dollars)
2020–21 federal theme planned spending
(dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target
Theme Area 5: Prevent and interdict prohibited cross-border movement of cannabis while maintaining the flow of legitimate travellers and goods CBSA:
$34,600,853
CBSA:
$7,784,168
Travellers understand the requirements to declare cannabis and cannabis-related products when entering Canada [CBSA] Percentage of ports of entry with displayed signage on cannabis [CBSA] 75% of major ports and 100% of other priority portsTable 42 Footnote 1 Achieved March 31, 2019
CBSA awareness tools are in place to inform travelling public on prohibition of cross-border movement of cannabis [CBSA] 100% of the digital strategy launchedTable 42 Footnote 2 Achieved March 31, 2019
Travellers are provided a clear opportunity to declare cannabis in their possession at all primary inspection sites [CBSA] Percentage of relevant primary inspection kiosks, systems, training materials, operational guidelines and forms in all modes updated [CBSA] 100%Table 42 Footnote 3 March 31, 2020
CBSA has enhanced capacity to promote compliance and to enforce import-related laws [CBSA] Number of cannabis import interdictions at ports of entry [CBSA] TBD by April 30, 2020 TBD by April 30, 2020
Prohibited cross border movement of cannabis detected Percentage of referred cannabis samples analyzed within 30 days [CBSA] 90% March 31, 2021
Travellers and the import/export community have access to recourse mechanisms to challenge certain CBSA actions and decisions in a timely manner [CBSA] Percentage of appeals received that are acknowledged within 10 calendar days [CBSA] 85% March 31, 2021
Percentage of Enforcement and Trusted Traveller appeals received that are decided within 180 calendar days [CBSA] 70% March 31, 2021
Percentage of Trade related appeals – Tariff Classification – that are decided within 365 calendars days (for cases never held in abeyance) [CBSA] 70% March 31, 2021
Percentage of cannabis-related complaints for which the CBSA contact the complainant within 14 calendar days after a written complaint is received [CBSA] 85% March 31, 2021
Percentage of cannabis-related complaints for which the CBSA provides a final written response to the complainant within 40 calendar days after a written complaint is received [CBSA] 90% March 31, 2021
Table 42 Footnote 1

This indicator has been achieved in fiscal year 2018-19 and is deemed complete.

Table 42 Return to footnote 1 referrer

Table 42 Footnote 2

A target will be established once two data points are collected.

Table 42 Return to footnote 2 referrer

Table 42 Footnote 3

This indicator will be deemed complete by March 31, 2020.

Table 42 Return to footnote 3 referrer

Theme 5 horizontal initiative activities
Departments Link to department's Program Inventory Horizontal initiative activity (activities) Total federal funding allocated to each horizontal initiative activity since last renewal
(dollars)
2020–21 planned spending for each horizontal initiative activity
(dollars)
2020–21 horizontal initiative activity expected result(s) 2020–21 horizontal initiative activity performance indicator(s) 2020–21 horizontal initiative activity target(s) Date to achieve horizontal initiative activity target
Canadian Border Services Agency Traveller Facilitation and Compliance Program Traveller awareness $1,008,014 $0 ER 5.1.1 PI 5.1.1.1 T 5.1.1.1 Achieved March 31, 2019
PI 5.1.1.2 T 5.1.1.2 Achieved March 31, 2019
Port of entry processing $20,952,092 $5,034,354 ER 5.1.2 PI 5.1.2 T 5.1.2 March 31, 2020
Regulatory compliance and enforcement $4,074,333 $973,669 ER 5.1.3 PI 5.1.3 T 5.1.3 TBD by April 30, 2020
Policy, Monitoring and Reporting $4,766,720 $845,701 Completed in 2018-19 Completed in 2018-19 Completed in 2018-19 Completed in 2018-19
Field TechnologyTable 43 Footnote 1 Laboratory Services $1,011,397 $241,015 ER 5.1.4 PI 5.1.4 T 5.1.4 March 31, 2021
Recourse Regulatory compliance and enforcement $2,788,297 $689,430 ER 5.1.5 PI 5.1.5.1 T 5.1.5.1 March 31, 2021
PI 5.1.5.2 T 5.1.5.2 March 31, 2021
PI 5.1.5.3 T 5.1.5.3 March 31, 2021
PI 5.1.5.4 T 5.1.5.4 March 31, 2021
PI 5.1.5.5 T 5.1.5.5 March 31, 2021
Table 43 Footnote 1

CBSA transitioned from the Program Alignment Architecture (PAA) to the Departmental Result framework (DRF) in fiscal year 2018-19. During the transition, CBSA continues to refine the activities within the program inventories, as such laboratory services is lined to Field Technology Support.

Table 43 Return to footnote 1 referrer

Total spending, all themesTable 44 Footnote 1
Theme Total federal funding allocated since last renewal
(dollars)
2020–21 total federal planned spending
(dollars)
Theme 1 $388,366,521 $94,686,368
Theme 2 $19,880,522 $1,812,013
Theme 3 $17,813,722 $3,859,638
Theme 4 $26,798,704 $4,968,523
Theme 5 $34,600,853 $7,784,168
Total, all themes $487,460,322 $113,110,710
Table 44 Footnote 1

Total spending, all themes table does not include Internal Services

Table 44 Return to footnote 1 referrer

Theme 1: Establish, implement and enforce the new horizontal initiative

Expected results

Health Canada

Royal Canadian Mounted Police

Performance indicators

Health Canada

Royal Canadian Mounted Police

Targets

Health Canada

Royal Canadian Mounted Police

Theme 2: Provide Canadians with information needed to make informed decisions and minimize health and safety harms

Expected results

Health Canada

Public Health Agency of Canada

Public Safety Canada

Performance indicators

Health Canada

Public Health Agency of Canada

Public Safety Canada

Targets

Health Canada

Public Health Agency of Canada

Public Safety Canada

Theme 3: Build law enforcement knowledge and engage partners and stakeholders on public safety

Expected results

Public Safety Canada

Royal Canadian Mounted Police

Performance indicators

Public Safety Canada

Royal Canadian Mounted Police

Targets

Public Safety Canada

Royal Canadian Mounted Police

Theme 4: Provide criminal intelligence, enforcement and related training activities

Expected results

Royal Canadian Mounted Police

Performance indicators

Royal Canadian Mounted Police

Targets

Royal Canadian Mounted Police

Theme 5: Prevent and interdict prohibited cross-border movement of cannabis while maintaining the flow of legitimate travellers and goods

Expected results

Canada Border Services Agency

Performance indicators

Canada Border Services Agency

Targets

Canada Border Services Agency

Gender-Based Analysis Plus

Governance structures

Launched in 2017, Health Canada’s Sex and Gender Action Plan provides a framework that strengthens the integration of sex, gender and diversity considerations (such as age and ethnicity) in externally as well as internally facing work of the Department. Note that the terms Gender-Based Analysis Plus (GBA+) and Sex and Gender-Based Analysis Plus (SGBA+) refer to the same concept. Health Canada has chosen to use SGBA+ to emphasize the fact that differences between women, men and gender-diverse individuals can be biological (sex related) and/or socio-cultural (gender related).

The purpose of the Plan is to establish the Department as an organization where sex, gender and diversity are systematically integrated into our decision-making processes. Foci of the Plan continue to be i) building departmental capacity; ii) strengthening our evidence-base and expertise; and iii) increasing accountability.

Monitoring, accountability and reporting mechanisms supporting the integration of sex and gender-based analysis plus (SGBA+) in departmental decision-making includes:

Human resources

In 2020-21, the total number of planned full-time equivalents (FTEs), dedicated to SGBA+ implementation in the Department is 19. This includes four full-time employees in the GHU, supporting employees across the Department. The other 15 FTEs consist of partial equivalents based on the work by other employees whose work is not exclusively focussed on sex and gender but who:

Planned initiatives

Health Canada incorporates a gender equality, diversity and inclusiveness lens in its work. The Department recognizes the importance of considering populations with unique needs when delivering its mandate to help Canadians maintain and improve their health.

Enhanced Capacity Building

Strengthened sex and gender related evidence and expertise

In order to strengthen the sex and gender related evidence available within the organization Health Canada will:

Considering Marginalized Canadians in Risk Communications

Addressing Health Inequities

In 2020-21, Health Canada is moving forward on several SGBA+ initiatives that have a specific focus on creating a more equitable landscape for health products and food in Canada. Some of these initiatives include:

Reporting capacity and data

SGBA+ is applied to all policies and programs developed in the department. The five programs listed below collect microdata on an individual level.

Most of our externally facing programs have a broad, higher level focus and do not collect individual level micro data.

Health Canada is in the process of completing a department wide data / information mapping exercise as part of the modernization of our Sex and Gender Information Practices. This exercise will identify all databases and datasets that include sex and / or gender identity information and review them to ensure that they are consistent with the new Treasury Board Secretariat (TBS) Policy Direction to Modernize the Government of Canada’s Sex and Gender Information Practices. This information will be reported as required by the TBS.

  1. Program Inventory 4: Mental Health
    1. The GBA+ relevant data captured is: geographic data (province/territory, postal code, etc.), sex, ethnicity, marital status, language. (Data Source – CCHS)
    2. Target population: individual Canadians.
    3. No Report
  2. Program Inventory 9: Medical Assistance in Dying (MAID)
    1. The GBA+ relevant data captured is: sex, age, province, ‘main’ condition.
    2. Target population: individual Canadians.
    3. Reported as follows:
      1. MAID Annual Report (Spring 2020).
  3. Program Inventory 13: Promoting Minority Official Languages in the Health Care Systems
    1. The GBA+ relevant data captured is: sex, profession, employment status.
    2. Target population: healthcare professionals.
    3. Reported as follows:
      1. Annually to Heritage Canada as part of Health Canada’s input to the federal Action Plan for Official Languages – 2018-2023: Investing in our Future.
  4. Program Inventory 15: Thalidomide
    1. The GBA+ relevant data captured is: sex, gender.
    2. Target population: individual Canadians.
    3. No report.
  5. Program Inventory 21: Food and Nutrition
    1. The GBA+ relevant data captured is: sex, gender, age, ethnicity. (data Source –CCHS)
    2. Target population: individual Canadians.
    3. No report.

Up-front multi-year funding

Canadian Foundation for Healthcare Improvement

General information

Recipient information

Canadian Foundation for Healthcare Improvement, formerly the Canadian Health Services Research Foundation

Start date

1996-97

End date

Not applicable

Link to departmental result(s)

Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems

Link to department’s Program Inventory

Program 1: Health Care Systems Analysis and Policy

Purpose and objectives of transfer payment program

When the Canadian Health Services Research Foundation (CHSRF) was established as an independent organization, its priorities were to bring researchers and decision-makers together to identify gaps in applied health services research, fund the researchers who could investigate those gaps, and promote best practices of health services delivery and their outcomes. To reflect the evolution of its work, CHSRF was renamed the Canadian Foundation for Healthcare Improvement (CFHI) in 2012. CFHI aims to: find and promote health care innovators and innovations; drive rapid adoption of proven innovations; enable improvement-oriented systems; and, shape the future of healthcare.

Up-front multi-year funding to CFHI included:

Additional federal grants were provided to CHSRF for the following purposes:

Total funding approved (dollars)

151,500,000

Total funding received (dollars)

1996 – 66,500,000
1999 – 60,000,000
2003 – 25,000,000

Planned funding in 2020−21 (dollars)

0

Planned funding in 2021−22 (dollars)

0

Planned funding in 2022−23 (dollars)

0

Note: CFHI is also reported under the “Details on Transfer Payment Programs” section of the Supplementary Information Tables.

Summary of recipient’s annual plans

CFHI works with patients, families and caregivers; health and social service providers; governments and other public and private sector organizations to accelerate the identification, spread and scale of proven healthcare innovations.

CFHI’s remaining up-front multi-year funding is being held in reserve to address costs associated with any negative revisions to CFHI’s future funding, should it be needed, for example, potential outcomes from the External Review of the Federally Funded Pan-Canadian Health Organizations.

Canada Health Infoway

General information

Recipient information

Canada Health Infoway (Infoway)

Start date

March 31, 2001Footnote 2

End date

March 31, 2015Footnote 3

Link to departmental result(s)

Core Responsibility 1: Health Care Systems
Result 1: Canada has modern and sustainable health care systems
Result 2: Canadians have access to appropriate and effective health services

Link to department’s Program Inventory

Program 6: Digital Health

Purpose and objectives of transfer payment program

Canada Health Infoway Inc. is an independent, not-for-profit corporation established in 2001 to accelerate the development of electronic health technologies such as electronic health records (EHRs) and telehealth on a pan-Canadian basis.

Between 2001 and 2010, the Government of Canada committed $2.1 billion to Infoway in the form of grants and up-front multi-year funding consisting of: $500 million in 2001 to strengthen a Canada-wide health infostructure, with the EHR as a priority; $600 million in 2003 to accelerate implementation of the EHR and Telehealth; $100 million in 2004 to support the development of a pan-Canadian health surveillance system; $400 million in 2007 to support continued work on EHRs and wait time reductions; and $500 million in 2010 to support continued implementation of EHRs, implementation of electronic medical records (EMRs) in physicians' offices, and integration of points of service with the EHR system. Infoway invests in electronic health projects in collaboration with a range of partners, in particular provincial and territorial governments, typically on a cost-shared basis. Project payments are made based on the completion of pre-determined milestones.

It is anticipated that Infoway's approach, where federal, provincial and territorial governments participate toward a goal of modernizing electronic health information systems, will reduce costs and improve the quality of health care and patient safety in Canada through coordination of effort, avoidance of duplication and errors, and improved access to patient data.

Total funding approved (dollars)

2,100,000,000

Total funding received (dollars)

2,093,398,112*

* This amount only represents funds disbursed to Infoway since its creation in 2001 up to November 2019, including the immediate lump sum disbursements in 2001, 2003 and 2004 totaling $1.2 billion as well as funds disbursed through cash flow requests under the 2007 and 2010 funding agreements.

Planned funding in 2020−21 (dollars)

To be determined(i)

Planned funding in 2021−22 (dollars)

To be determined(i)

Planned funding in 2022−23 (dollars)

To be determined(i)

(i) As per both the 2007 and 2010 contribution agreements, funds are to be disbursed according to the annual cash flow requirements identified by Infoway. These requirements are to be submitted to Health Canada no later than March 30, in advance of the upcoming fiscal year to which that cash flow statement applies. Also, Infoway can submit additional cash flow requests within a fiscal year, should the need for additional funding arise.

Note: Budget 2017 contribution funding to Infoway is reported under the “Details on Transfer Payment Programs” section of the Supplementary Information Tables.

Summary of recipient’s annual plans

The following is a summary of plans related to up-front multi-year funding.Footnote 4

At its inception in 2010, Infoway received $2.1 billion in up-front multi-year funding from the federal government. This funding was invested in 12 programs (e.g., EMR and EHR) by the Board. Each program was broken down by jurisdictions into smaller projects. As of March 31, 2019, Infoway has spent $2.014 billion of the original $2.1 billion and has made commitments for the remaining $86 million. An estimated $49 million of the $86 million will be spent in 2019-20.

Infoway is currently undertaking its Driving Access to Care Strategy which is comprised of two programs: PrescribeIT and ACCESS Health. To date, 10 jurisdictions have formally agreed to participate in the PrescibeIT program (all except for Nunavut, Quebec, and British Columbia). Infoway has also secured partnerships with several distributers. Infoway also continues to develop its ACCESS Health program. It is currently designing two facets of the program: Access Atlantic and Access Gateway. As a part of the ACCESS Health Program, Infoway is developing a national trust framework to help protect the privacy and manage the consent of patients.

Footnotes

Footnote a

Assessing the risks to human health from substances is complex, as it often includes data gathering and working with other jurisdictions and stakeholders. As a result, delays in the development of the risk assessment documents may occur. The Program will continue to streamline processes and look for further efficiencies in order to continuously strive towards the target of 100%.

Return to footnote a referrer

Footnote b

This target is aspirational. Managing risks to human health from substances is complex, as it often includes research, consultations with stakeholders and analyzing socio-economic impacts. As a result, delays in the development of the proposed and final risk management actions may occur. The Program will continue to streamline processes and look for further efficiencies in order to continuously strive towards the target of 100%.

Return to footnote b referrer

Footnote c

Assessing the risks to the environment from substances is complex, as it often includes data gathering and working with other jurisdictions and stakeholders. As a result, delays in the development of the risk assessment documents may occur. The Program will continue to streamline processes and look for further efficiencies in order to continuously strive towards the target of 100%.

Return to footnote c referrer

Footnote d

This target is aspirational. Managing risks to the environment from substances is complex, as it often includes research, consultations with stakeholders and analyzing socio-economic impacts. As a result, delays in the development of the proposed and final risk management actions may occur. The Program will continue to streamline processes and look for further efficiencies in order to continuously strive towards the target of 100%.

Return to footnote d referrer

Footnote 1

This is not a repayable contribution.

Return to footnote 1 referrer

Footnote 2

The original allocation (2001) was governed by a Memorandum of Understanding. Presently, Infoway is accountable for the provisions of three active funding agreements, signed in: March 2003 (encompasses 2001 and 2003 allocations), March 2004, and March 2010.

Return to footnote 2 referrer

Footnote 3

As per the 2010 funding agreement, the duration of the agreement is until the later of: the date upon which all Up-Front Multi-Year Funding provided has been expended; or March 31, 2015. Funds from the 2007 funding agreement (which was signed in March 2007) were expended in 2018-19.

Return to footnote 3 referrer

Footnote 4

Note that this section focuses on Infoway legacy activities remaining from historical up-front multi-year funding agreements. The bulk of Infoway's current activities relate to Budget 2017 contribution funding to Infoway, which is reported under the section "Details on Transfer Payment Programs."

Return to footnote 4 referrer

Footnote 5

The Canadian Drugs and Substances Strategy (CDSS) covers a broad range of legal and illegal substances, including cannabis, alcohol, opioids and other kinds of substances that can be used problematically.

Return to footnote 5 referrer

Footnote 6

Baseline: 21% in 2017

Return to footnote 6 referrer

Footnote 7

Baseline: 61% in 2017

Return to footnote 7 referrer

Footnote 8

Enhanced capability is reference to six additional dog teams and the introduction of the fentanyl scent (through training) to existing teams

Return to footnote 8 referrer

Footnote 9

Baseline is 0 as these are new facilities not yet established and no officers have been trained.

Return to footnote 9 referrer

Footnote 10

Baseline: 1000 from September 2017 to February 2018

Return to footnote 10 referrer

Footnote 11

Includes national reports, peer-reviewed (scientific) journal articles, infographics, factsheets, and related analytical products

Return to footnote 11 referrer

Footnote 12

While cannabis is encompassed by the CDSS, federal activities, performance measures and funding amounts are reported on through a separate horizontal initiative (Implementing a Framework for the Legalization and Strict Regulation of Cannabis).

Return to footnote 12 referrer

Footnote 13

Additional federal activities to address the opioid crisis are reported through a separate horizontal initiative (Addressing the Opioid Crisis).

Return to footnote 13 referrer

Footnote 14

The United Nations Annual Report Questionnaire is in the process of being revised, and this performance indicator and target will be reviewed in 2021.

Return to footnote 14 referrer

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: